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This thesis follows the portfolio model of work carried out in part-fulfilment of the Doctorate in 
Clinical Psychology at the University of Edinburgh. An abstract provides an overview of the 
whole thesis, its findings and implications. Chapter 1 consists of a systematic review looking at 
the published research into the mental health and social support in adolescents and adults with 
cystic fibrosis (CF). This review is written for submission to Clinical Psychology Review for 
publication and follows their author guidelines. Chapter 2 links the systematic review to the 
thesis project and outlines its aims and research questions. The main project is then presented as 
two separate studies. Study 1 is a quantitative assessment of the mental health, quality of life and 
self-esteem in adults with CF and the relationships between these factors. The methods and 
results for this study are presented in chapters 3 and 4 respectively. Chapters 5 and 6 present the 
methods and results of Study 2. This is a qualitative exploration of the way adults with CF make 
use of an online discussion forum. The findings of studies 1 and 2 are brought together within 
chapter 7 which forms the thesis discussion. This chapter contains consideration of the results in 
the context of existing published literature, their limitations and clinical implications. Chapter 8 
presents Study 1 written up in the form of a journal article. This follows author guidelines for 
submission to the Journal of Cystic Fibrosis. The final two sections of the thesis portfolio 





Background: Improvements in cystic fibrosis (CF) treatment over the last two decades have 
brought large increases in life expectancy. As a result, researchers have become more interested 
in the long-term quality of life and psychological wellbeing of adults with CF. Introduction of 
segregation policies to prevent cross-infection have added a new dimension to life with CF; 
patients are discouraged from meeting face-to-face and this impacts on access to peer support.  
Systematic review: A systematic search of the published literature since 1990 identified 10 
journal articles describing research with adolescents and adults with CF, their mental health 
needs and social support or functioning. Quantitative papers indicated an inverse relationship 
between mental health and social support or social functioning. 
Objectives: The internet has become increasingly used for social networking and accessing 
social support resources. This thesis aimed to explore the psychological wellbeing of adults with 
CF who make use of online social support and the themes emerging within online discussion 
forums. 
Method: Study 1 is a quantitative survey carried out online which assesses the quality of life, 
mental health and self-esteem of 74 adults with CF.  Study 2 uses framework analysis to provide 
a qualitative exploration of posts made by participants on an online discussion forum. 
Results: Moderate levels of quality of life and comparably high levels of self-esteem were found. 
Thirty per cent of the sample population scored above threshold for clinical levels of mental 
health difficulty. Significant correlations indicated that poorer self-esteem was associated with 




discussion forum posts including CF treatment, daily living and occupation, health 
exacerbations, psychosocial processes and issues and the future. 
Conclusions: Self-esteem and mental health scores were similar to previous research. However, 
quality of life was noted to be considerably lower when compared to other research samples. 
This was thought to be influenced by the overrepresentation of females in the current sample but 
may also be reflective of the group of people with CF who make use of online resources. Results 
are discussed in relation to clinical implications, limitations and directions for future research, 
including the efficacy of internet groups in improving wellbeing and consideration of possible 




1 SYSTEMATIC REVIEW 
1.1 ABSTRACT 
Cystic fibrosis (CF) has considerable impacts on socialisation due to treatment demands and 
segregation policies designed to protect against physical health decline. The prevalence of 
mental health difficulties within the CF population has been shown to vary with age, gender and 
work status. They also impact negatively on quality of life and treatment adherence. Few studies 
include consideration of how social support influences psychological well-being in people with 
CF. The current review aims to examine the findings of published literature which looks at the 
relationship between mental health and social support in adolescents and adults with CF. Online 
database and hand searches of relevant journals led to the identification of 9 articles eligible for 
review. Quantitative papers supported an inverse relationship between mental health symptoms 
and social support. Factors which may influence this relationship are discussed, including 
severity of illness. The findings are discussed with consideration for statistical weaknesses and 
future research possibilities.  
 
Key Words: cystic fibrosis, mental health, social support, systematic review 
 
Highlights: 
• Systematic review of papers considering mental health and social support in people with CF 
• Few papers exist which examine this relationship 
• Available research suggests a negative correlation between the two variables 
• Online social environments may help people with CF overcome segregation policies to 





1.2.1 Overview of cystic fibrosis 
Over 8500 people in the UK suffer from cystic fibrosis (CF), one of the most common life-
threatening inherited diseases in the UK (CF Trust, 2011). CF primarily affects the lungs and 
digestive system (Ernst, Johnson, & Stark, 2010) whilst additional problems with liver function, 
fertility, bone density or CF-related diabetes (CFRD) may develop throughout the life-course 
(Ernst, et al., 2010). Advances in treatment have led to drastic increases in median life 
expectancy, which is currently reported to be 38 years old (CF Trust, 2011). However, daily 
treatment regimes for CF are time-consuming and complex, often taking between 2 to 4 hours 
each day (Quittner, Barker, Marciel, & Grimley, 2009). Ordinarily, treatment consists of a 
combination of medication (e.g. inhaled antibiotics, oral digestive enzymes), high calorie diet, 
chest physiotherapy and exercise. These treatments help to mobilise thick secretions of mucus in 
the airways, improve the gas exchange processes between the lungs and blood stream and 
improve the absorption of nutrients in the digestive system.  In addition, patients often receive 
intravenous antibiotics as hospital inpatients to treat respiratory infections.  
 
The build up of mucus in the lungs makes people with CF more vulnerable to infections which 
can have detrimental consequences for lung function and physical health. The frequency of 
infections and exacerbations often increases with age and results in greater treatment burden and 
stress (Ernst, et al., 2010). In an attempt to minimise the cross-infection of particularly harmful 
bacteria, such as pseudomonas aeruginosa, segregation policies were introduced in the early 
1990’s to separate CF patients on the grounds of their infection status (Littlewood, 2004). 
Strains of these infections acquired from fellow patients are harder to treat than those contracted 




the psychological impact (Geddes, 2001), segregation policies have reduced the opportunity for 
people with CF to meet and interact with their CF-peers whilst increasing stigma and isolation 
experienced by patients (Quittner, et al., 2009; Russo, Donnelly, & Reid, 2006). 
1.2.2 Health-related quality of life (HRQoL) and mental health 
With the vast majority of people with CF now living into adulthood, researchers have become 
increasingly interested in long-term quality of life and psychological well-being. A past review 
paper by Pfeffer and colleagues (Pfeffer, Pfeffer & Hodson, 2003) provided an overview of 
research pertaining to psychological aspects of CF, including mental health and quality of life. 
Their paper recognised the variability in findings regarding factors which may be influential for 
the mental health of people with CF, such as gender, age, coping style and severity of illness. 
Although the review is informative and appears to provide a summary of some key factors 
involved in the psychosocial aspects of cystic fibrosis, it appears not to have been conducted in a 
systematic manner. The authors did not report their strategy for searching the literature nor 
whether the quality of papers was considered in the synthesis of their findings.  
 
Since Pfeffer, et al.’s (2003) review, there have been numerous publications which further 
explore the quality of life and mental health of people with CF. Studies have indicated that 
adolescents and adults with CF report high levels of quality of life despite the large treatment 
demands and shortened life-span in CF (Ernst, et al., 2010; Szyndler, Towns, van Asperen, & 
McKay, 2005). On the contrary, research studies into rates of mental health symptoms have 
presented a more variable picture. Some studies suggest higher levels of depression and/or 
anxiety compared to the general population (Bregnballe, Thastum, & Schiøtz, 2007; Goldbeck et 
al., 2010; Modi, Driscoll, Montag-Leifling, & Acton, 2011; Quittner et al., 2008), whereas others 




(Anderson, Flume, & Hardy, 2001; Szyndler, et al., 2005). The reasons for this variability 
continue to be explored by research with recent influential factors shown to include gender, age, 
work status and severity of illness (Bregnballe, et al., 2007; Burker et al., 2004; Goldbeck, et al., 
2010; Modi, et al., 2011; Pearson, Pumariega, & Seilheimer, 1991; Quittner, et al., 2008). 
1.2.3 Social Support 
The research literature has frequently acknowledged the time-consuming nature of CF treatment 
regimes and, intuitively, that time spent on treatment decreases the time available to engage in 
other activities such as socialising (Modi, et al., 2011). Peer relationships have been seen to be 
affected in other chronic illnesses (Forgeron et al., 2010) and, with the use of segregation in CF 
services, it is important to consider how people with CF can build and maintain relationships 
with their CF peers (Quittner, et al., 2009; Russo, et al., 2006). Quality of life measures usually 
include assessment of social functioning (Cella, 1998; Spilker, 1996) but this may be 
conceptually different to social support. The term social functioning suggests looking at how 
well people are able to take part in social activities or interactions. Social support, however, 
suggests looking at the availability of support which is sought from or provided by family, 
friends, health professionals or work colleagues. In the general population without chronic health 
conditions, higher levels of social support are important for adaptation to stress and are related to 
lower levels of mental health difficulty (Cohen & Wills, 1985; Coyne & Downey, 1991; Hefner 
& Eisenberg, 2009; Holahan & Moos, 1981).  In papers specifically focusing on social support 
in CF, peer relationships have been shown to be important in buffering against the negative 
effects of poor family relationships (Herzer, Umfress, Aljadeff, Ghai, & Zakowski, 2009). In 
addition, social support from others, including family members and friends, is related to better 
coping and improved adherence to CF treatment (Barker, 2010; White et al., 2009). Key 




support may have on depression in CF patients (Modi, et al., 2011) and explore how new 
technologies may enhance peer interaction for this group (Quittner, et al., 2009).   
1.2.4 Aim of review 
In light of the potential importance of social support for patients with CF and its likely influence 
in mental health and psychological well-being, it was considered that a review of the published 
literature in this area may be beneficial. Pfeffer, et al.’s (2003) review briefly mentioned the 
possible impacts of social support on mental health but this was not a key focus of their paper. 
They provided a much wider summary of research into the psychosocial aspects of CF published 
since 1990 (Pfeffer, et al., 2003), but it was unclear whether papers were identified or 
approached in a systematic manner. In order to provide a more focussed and systematic 
examination of the literature which considers relationships between social support and mental 
health in people with CF it was felt that a further review would be beneficial. Given the paucity 
of research using specific measures of social support, papers including measures of social 
functioning were also of interest. Therefore, the aim of this current review was to provide a 
systematic evaluation of research published since 1990 which considers the importance of and 
possible relationships between social support and mental health in adolescents and adults with 
cystic fibrosis.   
1.3 METHOD 
1.3.1 Literature search strategy 
EMBASE, PsycINFO and MEDLINE online databases were searched between January 1990 and 
January 2011. These databases were chosen to cover a range of online journals from the social 
sciences, nursing and medical disciplines. Titles, abstracts and keywords were searched using 




OR friendships) AND (mental illness OR mental health OR mental disorder OR psychosocial 
OR self-esteem OR anxiety OR depress* OR psychological wellbeing). A manual search of the 
contents pages of four keys journals, namely the Journal of Pediatric Psychology, Journal of 
Cystic Fibrosis, Chest and Journal of Health Psychology, was also conducted over the same time 
period to ensure the inclusion of key papers which may have been missed by electronic database 
searches.  
 
Search results were assessed using predetermined inclusion and exclusion criteria (see Table 
1.1). In the first instance, titles and citations of papers were screened for the presence of 
exclusion criteria. Those meeting at least one of these exclusion criteria were discarded. For the 
remaining papers, abstracts were assessed for inclusion. In order to ascertain a level of criteria 
reliability, an independent clinical psychologist experienced in qualitative and quantitative 
research was involved in the assessment process. Due to time limitations, it was not possible for 
all abstracts to be assessed by a second researcher, therefore a random sub-set of 20 abstracts 
were rated using the protocol and criteria developed a priori. Agreement on eligibility was found 
for 19 out of 20 papers. Three of the 19 papers were obtained in full-text to clarify eligibility 
because both reviewers felt that a decision could not be made about inclusions based on the 
abstract alone. The single discrepancy applied to a reference for a conference abstract; initial 
criteria were revised to ensure this was identified as a reason for exclusion.  
 
Full-text articles were obtained for studies which could not be excluded on the basis of the 
abstract. Final assessment of eligibility was carried out on full-text articles and those meeting 
criteria were included in the review. In order to identify additional papers which may have been 
missed from electronic searches two strategies were used: reference lists of identified journal 





In total, 23 full-text papers were obtained for final assessment for inclusion by the primary 
researcher. Of these papers, 14 did not meet inclusion criteria; reasons included lacking a mental 
health measure, no consideration of social support or focusing on parents and siblings without 
CF. The selection process is illustrated in Figure 1.1 and provides the number of studies 
discarded at each phase and reasons for rejection.  
 
Table 1.1 Inclusion and exclusion criteria for systematic review articles 
Inclusion Exclusion 
 Participants have CF 
 13 years old + 
 Peer-reviewed research articles 
 English language 
 Measurement or report of mental health 
 Measurement or report of social support 
or social functioning 
 Participants are: 
• Children with CF <13 years old  
• Parents or carers without CF 
• Adolescents or adults without CF 
 Non-peer reviewed research: 
• Book chapters 
• Book reviews 
• Conference Abstracts 
• Letters 
• Theses/Dissertations 
 Non-English language article 
 
1.3.2 Data extraction and quality assessment 
A standard proforma for assessment of article quality and data extraction was developed in 




for methodological rigour and quality. Checklists provided by the Scottish Intercollegiate 
Guidelines Network within ‘SIGN 50: A guideline developer’s handbook’ (2008) were adapted 
to provide relevant critique of the design and quality of quantitative papers as eligible. The SIGN 
50 quality criteria checklists are based on the MERGE (Method for Evaluating Research and 
Guideline Evidence) checklists developed in Australia (Liddle, Williamson, & Irwig, 1996). 
These guidelines have been used internationally for systematic reviews published in peer-
reviewed journals (e.g. Glare, et al., 2004; Ishihara & Brayne, 2005; Liang, et al., 2010; Soon, et 
al., 2009). Qualitative papers were scrutinised using an alternative framework from the Critical 
Appraisal Skills Programme [CASP] (Public Health Resources Unit, 2006) with additional data 
extraction questions. A copy of both frameworks can be found in Appendix A. 
 
 
Figure 1.1 Flowchart of systematic review paper selection process 
Online database search: 
(EMBASE, Medline, PsycINFO) 
 
76 titles 







Reference list and 
citation search: 
1 additional paper 
Titles rejected: 38 
 
(Reason: 11 not peer-
reviewed article; 7 foreign 







Abstracts rejected: 45 
 
(Reasons: 14 no mental health, 
13 no social support, 8 
parents/family; 4 too young, 5 
no outcome measures; 1 review 
paper;) 
 
Unable to access full-
text article: 1 
Full-text included: 
9 
Full-text rejected: 13 
 
(Reasons: 5 no social 
support, 4 no mental health; 
2 parents/friend; 1 too 








Of the 9 papers identified and included in the final review, 7 were quantitative and 2 were 
qualitative in nature. These papers will be summarised using a narrative approach, considering 
quantitative papers in the first instance, followed by the qualitative papers. 
1.4.1 Quantitative studies 
The seven quantitative papers deemed eligible for inclusion in the review varied in focus and the 
majority took a cross-sectional approach to assessing variables within a population of patients 
with CF. One exception to this was Casier’s (2011) prospective study of the role of acceptance 
in well-being. An overview of the studies is provided in Table 1.2. Data outlining each study’s 
sample is given where possible. Where available, this includes report of FEV1% predicted 
(forced expiratory volume in 1 second, per cent predicted) which is a frequently used measure of 
lung function and indicator of illness severity where higher percentages indicate better 
respiratory functioning. The papers will be summarised in terms of their mental health and social 
support findings and then the relationships found between these two factors. It is acknowledged 
that eligible papers do not represent the wider research literature in the area of mental health 
needs in the CF population, but it was considered important to summarise the findings within 
each of these areas before joint consideration. 
1.4.1.1 Mental health and psychological well-being 
The papers within the selected sample provide some insight into the mental health of people with 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































assessment of the psychological needs of the adult CF population and explore predictive 
variables associated with better psychological functioning. In their sample of 34 adults with CF, 
they discovered levels of depressive symptoms and anxiety which were comparable to the 
general population. Subsequent papers in the current review reported similar findings (Casier, et 
al., 2011; Havermans, Colpaert, & Dupont, 2008; Szyndler, et al., 2005). A slightly earlier paper 
by Burker, Carels, Thompson, Rodgers and Egan (2000) found that a sample of patients with CF 
awaiting lung transplantation had lower levels of mental health difficulty than those with other 
end-stage lung diseases also awaiting transplant. In contrast, an interesting paper by Delelis, 
Christophe, Leroy, Vanneste and Wallaert (2008) examined the psychological functioning, 
coping and marital satisfaction in sixteen couples in which one person had CF. Although the 
sample size was small, the authors found that there were no differences in the levels of mental 
health symptoms between patients with CF and their healthy partners. Both patients and partners 
experienced higher levels of anxiety than depression. Despite the lack of difference between 
partners and patients, the proportion of participants (both patients and partners) experiencing 
clinical levels of anxiety or depression was higher than indicated in the general population. Five 
out of the 16 patients (31 per cent) and 7 out of 16 (44 per cent) partners scored above the cut off 
for significant anxiety symptomology. For depressive symptoms, 4 patients (25 per cent) and 2 
partners (12.5 per cent) scored above cut-offs for possible cases of depression. Rates of anxiety 
and depression in the general population are suggested to be in the region of 16 per cent 
(Singleton, Bumpstead, O'Brien, Lee, & Meltzer, 2001). 
 
A larger study also identified elevated levels of depression amongst a sample of 76 adults with 
CF (Riekert, Bartlett, Boyle, Krishnan, & Rand, 2007). Whilst exploring the relationships 
between quality of life and mental health, Riekert et al. (2007) noted the presence of depressive 




Steer, & Barbin, 1988). However, this finding was not replicated within a study by Havermans et 
al. (2008) who aimed to further explore the relationships between mental health and lung 
functioning using the Hospital Anxiety and Depression Scale [HADS] (Zigmund & Snaith, 
1983). The exact reason for the contrast between Riekert et al.’s (2007) and Delelis et al.’s 
(2008) findings compared with other studies is not clear but it may be due to the assessment 
measures used, sample size, age of participants or factors which are not apparent from the 
reported methodology. 
1.4.1.2 Social support and social functioning 
Only two papers identified for review made use of standardised measures designed explicitly to 
measure social support (Anderson, et al., 2001; Burker, et al., 2000). Another two papers 
included consideration of social support through using measures of coping and family 
environment (Delelis, et al., 2008; Szyndler, et al., 2005). Delelis et al. (2008) found that, in 
their small sample of participants with CF, seeking social support was used as a coping strategy 
more often in those with a more severe classification of CF. The remaining papers mentioned 
social aspects of their participants’ lives through the use of the social functioning subscale of the 
Cystic Fibrosis Questionnaire - Revised [CFQ-R] (Quittner, Buu, Watrous, & Davis, 2002). In 
general, papers suggested that CF patients have high levels of perceived social support 
(Anderson, et al., 2001; Burker, et al., 2000) and social functioning (Casier, et al., 2011; 
Havermans, et al., 2008; Riekert, et al., 2007; Szyndler, et al., 2005) despite potential difficulties 
in interpersonal relationships (Pfeffer, et al., 2003). 
1.4.1.3 Relationships between mental health and social support 
Although not all papers carried out correlations between measures of mental health and social 




correlation between mental health difficulty and social support or functioning. Higher levels of 
social support were related to lower levels of depression (Anderson, et al., 2001) and anxiety 
(Anderson, et al., 2001; Burker, et al., 2000). Similarly, higher levels of social functioning were 
related to lower levels of anxiety (Casier, et al., 2011; Havermans, et al., 2008), depression 
(Casier, et al., 2011; Riekert, et al., 2007) and global measures of mental health symptoms 
(Szyndler, et al., 2005). People with CF living in a supportive family environment, in particular 
families with higher levels of cohesion, expressiveness and organisation, appeared to have lower 
levels of psychopathology and better emotional functioning (Szyndler, et al., 2005). The types of 
coping used by adults with CF differed depending on levels of depression and anxiety: those 
with higher levels of anxiety or depression relied on emotional coping strategies rather than 
social support strategies (Delelis, et al., 2008). 
 
Due to the nature of assessing relationships using correlations of cross-sectional data, it is not 
possible to infer causality. As a consequence, it is unclear whether higher levels of social support 
or social functioning serve as a protective factor against developing mental health difficulties or 
whether the development of mental health difficulties reduces the levels of social functioning or 
perceived social support. Longitudinal studies would be required in order to make inferences 
about the causality in this relationship. 
1.4.1.4 Additional influential variables 
The studies mentioned within this review present evidence for a negative correlation between 
mental health symptoms and social support and functioning. However, a number of the studies 
reveal that this relationship is likely to be complex and influenced by a number of other 
variables. Physical health status or disease severity, gender and level of acceptance were noted in 





It has been shown that when physical health status is factored into data analysis, significant 
relationships between mental health and social functioning scores persist (Havermans, et al., 
2008; Riekert, et al., 2007). This indicates that physical health status does not account for the 
relationship between social support and mental health but it seems that social support may act as 
a moderator for the relationship between physical health status and mental health. In Anderson et 
al.’s (2001) paper, regression analyses revealed better psychological functioning to be predicted 
not only by higher levels of social support but also by being female and being in better physical 
health. Reikert et al. (2007) also noted a significant relationship between better lung functioning, 
fewer depressive symptoms and better quality of life. Moreover, they also showed that those 
with poorer lung function (FEV1% predicted < 70%) had three times the odds of scoring above 
the clinical cut-off score on the BDI. A further paper highlighting the influences of physical 
health status was that by Delelis et al. (2008) who noted the potential impact of physical health 
status in the differential use of coping strategies employed depending on CF severity. Those who 
were rated as having “major” CF (based on a number of physical health indicators) were seen to 
identify social support as a coping strategy significantly more than those rated with “minor” CF. 
The greater identification of social support as a coping strategy in those with major severity CF 
may be a possible reason why levels of anxiety or depression were no higher in this group 
compared to the minor CF severity group 
 
A final influential factor is level of acceptance. Casier et al.’s (2011) study indicated the 
important role of acceptance in the symptoms of mental health at two time points six months 
apart. They found that higher levels of acceptance were associated with fewer depressive 
symptoms at both time points. Social functioning, as well as other sub-domains of quality of life 




acceptance was found for anxiety. The authors acknowledge that their small sample size may 
have led to small or medium effects within data being overlooked and that further research is 
required. However, their study suggests that acceptance may play a protective role for patients 
with CF and that it perhaps has a positive influence on mental health and quality of life, 
including social functioning. 
1.4.2 Qualitative Studies 
Two qualitative studies were identified as eligible for inclusion within the present systematic 
review (Durst et al., 2001; Macdonald, 2006). Both considered the experience of CF patients in 
relation to lung transplantation, but where Macdonald (2006) focused on the period of time 
waiting for lung transplantation, Durst et al. (2001) explored experiences post-transplantation. 
Macdonald (2006) presents a clear and robust methodology involving semi-structured interviews 
with eight adult CF patients, 4 pre- and 4 post-lung transplant. The author’s content analysis 
revealed four themes running through the interview data: displacement, disorder, life in limbo 
and readjustment to wellness. In relation to the current review, Macdonald’s (2006) participants 
described experiencing “disordered emotions” whilst attending assessment for lung transplant 
and when adjusting after transplant. The need for emotional and practical support from loved-
ones, carers or other post-transplant peers was highlighted as important when coping with 
emotional difficulties triggered by the process.  
 
Durst et al.’s (2001) study similarly considered psychological functioning and social aspects of 
life for CF patients in relation to lung transplantation. Their cohort of 19 adolescents who had 
undergone transplant was interviewed on topics including psychological and social functioning. 
The paper reports that adolescents functioned well in terms of their psychological and emotional 




esteem, a variable which is often linked with better mental health (Mann, Hosman, Schaalma, & 
de Vries, 2004). Interviews also revealed that participants felt their transplant had improved their 
social interactions with peers, which in turn may influence accessibility of social support. 
However, in contrast to Macdonald (2006), Durst et al.’s (2001) report of their qualitative 
methodology and data analysis strategies lacked detail and made no reference to the methods 
used. Although this article sheds light on the experiences of adolescents with CF post-transplant, 
the quality assessment of the paper indicated a marked lack of scientific rigour. There was no 
consideration of potential biases such as: the influence of interviewer, the context in which the 
questions were being asked, the method of analysis used or the possible influence of researcher 
bias during the analysis process. The poor presentation of the methods compromises the validity 
and robustness of the findings.  
 
The qualitative studies fit well with the quantitative papers discussed previously. Macdonald’s 
(2006) study indicated that patients required social support when going through the transplant 
process, a time when lung functioning and physical health are particularly poor, in order to cope 
more effectively with emotional difficulties. Durst et al. (2001) describe links between better 
physical health, provided by the lung transplant, increased self-esteem and social interaction. 
These factors perhaps all contribute to better psychological well-being. 
1.5 DISCUSSION 
Relatively few published studies were found which looked at mental health and its relationship 
with social support in adolescents and adults with CF. Identified studies which met criteria 
suggested an inverse relationship between social support and mental health symptoms, i.e. those 
with greater social support or social functioning appear to experience lower levels of 




be clarified and it is still not clear to what extent some factors such as disease severity and 
acceptance play a role. It may be that these factors moderate the relationship, or alternatively, 
that social support moderates the relationship between disease severity and psychological well-
being. 
 
Whilst carrying out the review, two areas for consideration came to light, namely choice of 
outcome measures and quality of papers, and these are discussed below. 
1.5.1 Choice of measures 
The studies included within the review employed a number of different measures to assess 
mental health and social support. It is understood that the choice of assessment measures 
depends on variables such as availability of measures within services, financial resources, 
researcher preference and the specific target variables within a project. The development of a 
reliable and valid CF-specific quality of life measure, namely the CFQ-R (Quittner, et al., 2002) 
has been beneficial to the research area. It provides insight into quality of life in several different 
domains including physical health, emotional functioning and social functioning. It is becoming 
more frequently used in projects and this enables some level of comparison across studies. 
However, despite inclusion of an emotional functioning sub-domain, it does not provide 
measurement of mental health symptoms per se and the choice of an additional measure for this 
purpose seems to vary a great deal. Within the seven quantitative papers included in this review, 
five different measures of mental health were used (BDI, HADS, CES-D, SCL-90-R, STAI), 
only some of which were reported to be reliable and valid within a physical health population. It 
is possible that some of the psychological difficulties faced by people with CF, such as 
adjustment to diagnosis, coping with lung transplantation and end-of-life issues, may not be 




the psychological needs of the CF population reliability and validity of existing measures may 
well be established but, for now, it is important to acknowledge their possible limitations. 
 
As a consequence of considering different measures used within the identified studies it was 
recognised that social aspects of life for patients with CF were reported in terms of social 
functioning or social support. These two terms seem to be used interchangeably within some 
research but may actually have important conceptual differences as outline in the introduction. 
Within this review, social support and functioning have been considered as two different 
concepts but, of course, social functioning may be a prerequisite for being able to access or 
benefit fully from social support. In his recent unpublished thesis, Barker (2010) has explored 
the concept of social support with adolescents with CF in order to develop an assessment 
measure for levels of support. Within this he emphasises the importance of separating out what 
people do from how this is perceived. That is, supportive behaviours may be helpful on some 
occasions but not on others depending on the context and perceptions of the person receiving the 
support (Barker, 2010). Overall, it is likely that both social functioning and social support are 
pertinent to patients with CF. Future research may wish to further explore their differences and 
potential impacts on mental health and psychological well-being in CF. In addition, it may be 
worth considering whether there are differential roles for family members, friends or significant 
others in providing support or enhancing the social functioning of people with CF. 
1.5.2 Quality of reported data 
Within reviews it is important to consider the methodological and scientific quality of research 
papers. Variability in the quality of papers was noted during the review process, although all 
quantitative papers were felt to be adequately designed. The majority of the studies made use of 




ranged between 16 to 76 participants. A common limitation was in the reporting of statistical 
power or accounting for multiple comparisons. Only two studies made reference to one of these 
considerations (Casier, et al., 2011; Riekert, et al., 2007) and not one study reported both the 
statistical power and use of corrections for multiple statistical comparisons. These two aspects of 
data analysis have implications for findings and confidence with which conclusions can be 
drawn. Psychological research commonly aims for a statistical power of .8 and adopts an alpha 
level of .05 (Barker, Pistrang & Elliot, 2002). When keeping these figures constant, studies with 
smaller numbers of participants may fail to identify small or medium effects (Barker, Pistrang & 
Elliot, 2002). Failing to account for multiple comparisons may result in the false identifications 
of significant results (Kinnear & Gray, 2008). The underreporting of these statistical 
considerations means that some of the studies identified for review may not be entirely 
representative of existing relationships.  
 
With regard to the quality of the two qualitative papers, Durst et al. (2001) failed to adequately 
report important methodological points such as the exact process for data collection, the method 
used for data analysis and consideration of reliability and validity of the analysis. Qualitative 
research has the potential to shed light on the lived experience of people with CF, but this needs 
to be conducted and reported in a manner just as rigorous as quantitative research in order to be 
viable. 
 
Despite the problems highlighted above in terms of possible statistical weaknesses within 
quantitative papers, their findings all suggest an inverse relationship between mental health 
symptoms and social support. It is perhaps the more subtle and finer points of this relationship, 
such as the influence of moderating variables, which may be misrepresented and therefore need 




account of likely statistical errors resulting from multiple comparisons on potentially 
underpowered research. 
1.5.3 Review limitations 
As discussed, most research has limitations and this review is no exception. The current review 
was aimed to provide an overview of the published research that considered mental health and 
social support or functioning in adolescents and adults with CF. As a result, it is recognised that 
those studies or papers which remain unpublished are not represented. The choice to include 
only published material was based on the availability of time and resources to obtain full-text 
copies of relevant literature. It may be useful in the future to repeat this review as more papers 
become published on the topic. A second limitation of this review is found in the fact that only 
one researcher carried out searches and selection of final papers. The project may have benefited 
from two or more researchers taking part in every stage of the review process but unfortunately, 
due to limited resources, this was not possible. Attempts were made to go some way towards 
minimising selection and assessment bias by involving fellow research colleagues in assessing a 
random subsection of abstracts for eligibility and collaborating on the standardisation of quality 
assessment and data extraction forms. Their limited input, however, means that ruling out bias 
entirely is not possible.   
1.6 CONCLUSIONS 
Research is beginning to investigate the role of social support for patients with CF and its 
relationships to mental health symptoms. This review of available published literature points 
toward an inverse relationship between these two variables. The impact of segregation policies 
on patients with CF and carers, their coping strategies and experience of mental health 




social support measures for people with CF (Barker, 2010) is encouraging and suggests that 
research within the area may become more prevalent in the coming years. 
 
Although the papers included in this review suggest levels of mental health difficulty as similar 
to the general population, these studies represent only the literature which includes consideration 
of social support or functioning. There is a much wider literature on the prevalence of mental 
health difficulties in CF and a current study is underway to assess this on an international scale 
(TIDES Project; www.Tides-CF.org). Initial reports from this project are indicating higher levels 
of mental health difficulty within this population and recommended timing for targeting mental 
health screening in CF services have been discussed (Goldbeck, et al., 2010; Modi, et al., 2011). 
Regardless of exact prevalence rates of mental health difficulty in CF, for the subset of CF 
patients who do experience mental health problems, psychological therapies may be beneficial. 
Empirical studies assessing the efficacy of psychological therapies are still very much in their 
infancy (Glasscoe & Quittner, 2008) and benefit cannot automatically be assumed. Traditional 
cognitive behavioural therapy (CBT) approaches often involve increasing behavioural activities 
and socialisation. For people with CF, health restrictions, both in terms of physical ability and 
segregation policies, may impede their opportunity to do this face-to-face. As an alternative to 
CBT, the recent studies implicating a role for acceptance in aspects of psychological wellbeing 
mean that acceptance and commitment therapy may have particular value for people with CF. 
This approach has a growing evidence base spanning a wide range of presenting difficulties 
(Kangas & McDonald, 2011; Pull, 2009). Future research could have two roles in this area. 
Firstly, investigating the efficacy of psychological therapies for people with CF and 
consideration of which components are most active. Secondly, an exploration of how using new 





Research currently underway in the USA is examining the impact of a new web-enabled mobile 
phone (the CFFone
TM
) on participants’ knowledge about CF, social support and treatment 
adherence (Marciel, Saiman, Quittell, Dawkins, & Quittner, 2010). Although it is unclear 
whether the researchers also intend to assess mental health or psychological wellbeing, it is 
possible that by providing this additional means of social support and contact with CF peers, 
psychological wellbeing may also be improved. In the UK and with regard to the broader 
spectrum of people living with chronic illness, a recent report has indicated that this population 
are not receiving adequate emotional and psychological support (Scottish Government and Long 
Term Conditions Alliance Scotland [LTCAS], 2011). The report recommends the development 
of services, for example via third sector organisations, to provide greater levels of social support 
for people with chronic health conditions in order to buffer against later difficulties which may 
require formal psychological services (Scottish Government & LTCAS, 2011). More specifically 
to CF, the World Health Organisation’s (2002) report recognises the psychosocial challenges 
faced by patients with CF. It mentions the relationship difficulties which may be encountered 
throughout life and the detrimental impact that segregation has had on access to peer support 
(WHO, 2002). To improve social support for CF patients, one possible avenue for exploration is 
the use of the internet and social networking sites which can offer opportunities for people with 
CF to interact without the risk of cross-infection. CF-specific discussion forums and online 
communities provide patients with an online environment for interacting with others in their 
situation which may help bridge the gap cleaved by the introduction of segregation policies. In 
addition to the research already being carried out in the USA, it may be useful to investigate the 
mental health needs of people with CF who already make use of existing internet resources, the 
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2 THESIS AIMS 
With the vast majority of people with cystic fibrosis (CF) now living into adulthood researchers 
have become increasingly interested in their long-term quality of life and psychological well-
being. Studies have indicated that the CF population report high levels of quality of life (Abbott, 
2009) but that levels of mental health difficulty vary. Some studies suggest higher levels of 
depression and/or anxiety compared to the general population (Goldbeck et al., 2010; Modi et 
al., 2011; Quittner et al., 2008) whereas others maintain that levels of mental health symptoms 
are comparable to the general population (Anderson et al., 2001). The reasons for this variability 
continue to be explored by research and factors identified as influential include being female, 
older, unemployed and having more severe illness (Goldbeck et al., 2010; Modi et al., 2011; 
Quittner et al., 2008). 
 
Two factors which have been shown to play an important role in the mental health of the general 
population are self-esteem and social support. However, these two variables have received 
relatively little attention within the CF literature. Self-esteem has been linked with better mental 
health and psychological wellbeing in the general population (Mann et al., 2004) and has been 
shown to play an important role in mediating the relationship between dysfunctional thoughts 
and depression in adult participants (Simpson et al., 2010). To the authors’ knowledge, only two 
papers have explicitly assessed self-esteem in adults with CF with both papers focusing 
primarily on body image (Abbott et al., 2000; Abbott et al., 2007). A recent publication by 
Brucefors et al. (10) speculated that low levels of self-esteem may have contributed to the higher 
levels of social dysfunction found in their sample of adults with CF compared with healthy 
adults. However, there was no direct measurement of self-esteem within their project and, as yet, 
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there appear to be no published studies which consider the relationship between self-esteem and 
mental health in adults with CF. 
 
Social support is important for adaptation to stress and higher levels of support are related to 
lower levels of mental health difficulty in the general population (Hefner & Eisenberg, 2009). 
Peer relationships have been seen to be affected in chronic illnesses (Forgeron et al., 2010) and, 
with the use of segregation in CF services to prevent cross-infection of respiratory bacteria, it is 
important to consider how people with CF can build and maintain relationships with and access 
support from their CF peers (Quittner et al., 2009). The evidence from CF research overall 
seems to indicate that higher levels of social support and better levels of social functioning are 
related to better coping (White et al., 2009), improved adherence to treatment (White et al., 
2009) and fewer mental health difficulties (Casier et al., 2011). Researchers have suggested that 
future studies continue to examine the potential buffering effects of social support (Modi et al., 
2011) and explore how new technologies may enhance peer interaction and overcome the 
restrictions of segregation for people with CF (Quittner et al., 2009).   
 
One option for keeping in contact with CF peers is to use the internet and social networking 
websites, where interactions can take place without the risks of cross-infection. Online resources 
are becoming increasingly popular (Hasenecz, 2010) and may provide an additional means of 
peer support for people with CF. However, little research has been carried out in the area of 
online resources, the characteristics of CF patients who make use of specific resources and the 
topics of discussion that arise.  
 
This thesis presents two studies aimed at adding to the existing literature on self-esteem in adults 
with CF and providing an exploration of how a CF-specific online discussion forum is used. 
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Study 1 consisted of a quantitative survey including standardised measures of mental health 
symptoms, self-esteem and HRQoL. Study 2 took a qualitative approach to explore the topics of 
discussion which arose within an online discussion forum hosted by a UK-based charity, the 
Cystic Fibrosis Trust (CF Trust). 
2.1 STUDY 1 - RESEARCH QUESTIONS 
The first study aimed to answer two primary research questions: 
a) What are the levels of mental health symptoms, HRQoL and self-esteem in adults 
with CF who make use of online discussion forums and internet resources?  
b) Are there significant correlations between measures of HRQoL, mental health and 
self-esteem in adults with CF? 
Levels of mental health difficulty were hypothesised to be similar to recent research in CF which 
has indicated a slight elevation in the prevalence of mental health difficulty when compared to 
the general population. In line with previous research involving the general population and CF 
patients, it was hypothesised that lower self-esteem would be related to poorer mental health and 
lower levels of quality of life.  
2.2 STUDY 2 - RESEARCH QUESTION 
The second study aimed to answer the following question:  
a) What topics are discussed and what types of support are sought from a CF-specific 
online discussion forum? 
2.3 ETHICAL CONSIDERATIONS  
Ethical approval for the two studies was sought and obtained from the School of Health in Social 
Science, University of Edinburgh research ethics panel (Appendix B). Collaboration with the 
Cystic Fibrosis Trust aided the process of refinement for the project to ensure that participants 
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were able to give fully informed consent. An information page posted on the CF Trust website 
provided details on how data would be used and stated that participants were able to withdraw at 
any time without giving a reason. Data were kept anonymous and participants chose whether to 
provide their online discussion forum username. The CF Trust provides guidance on using their 
online forum and advises users not to provide any identifying personal information. Forum 
usernames were only used to identify discussion board posts to be included in qualitative 
analysis. Participants were informed that any direct quotes used within the report would not 
include the username of its author. At the end of the online survey, a number of support contacts 
were included and participants were encouraged to speak with a member of their health team if 
any items within the standardised measures had raised issues for them.  
Study 1 - Methods 
 38 
3 STUDY 1 METHODS 
3.1 DESIGN 
This was a one time-point observational study of a population of adults with cystic fibrosis 
who made use of online discussion forums and social networking. Participants completed 
three quantitative assessment measures and provided demographic information.  
3.2 PARTICIPANTS 
Participants were recruited through an online discussion forum and Facebook social 
networking page hosted by the Cystic Fibrosis Trust (CF Trust), a UK-based charity. A total 
of 105 eligible participants consented to take part in the study. Surveys were completed to 
varying levels with fully completed data sets submitted by 74 participants (see Table 3.1). 
 
Table 3.1 Number of survey sections completed out of 105 consenting participants 
Survey Section Number (%) completed  
Demographic information 89 (84.8) 
CFQ-R 78 (74.3) 
CORE-OM 34 75 (71.4) 
Rosenberg self-esteem 75 (71.4) 
 
Full sets of data 
N = 74 (70.1%) 
Username only 5 (4.8)  
No information given 11 (10.5)  
 
Key demographic details for full and partially completed surveys are presented in Table 3.2. 
Non-parametric comparisons of key characteristics of full- and partial- completers were 
carried out using chi-squared and Mann-Whitney U tests. There were no significant 
differences between groups on any variable: age (U = 383.5; exact p = .14, n.s.); FEV1% 
predicted (U = 294.0; exact p = .69, n.s.); gender (x
2
 = 3.56; exact p = .11, n.s.); ethnicity (x
2
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= 0.60; exact p = 1.00, n.s.); country (x
2
 = 0.20; exact p = 1.00, n.s.); lung transplant (x
2
 = 
0.02; exact p = 1.00, n.s.). These results indicate that the two groups of participants did not 
differ significantly in terms of demographic variables. A more detailed breakdown of 
demographic variables for those participants completing a full set of survey data are 
presented in Table 3.3. 
 
Table 3.2 Key demographic characteristics of full and partial surveys completed 
 Full Partial 
N 74 15 
Age (mean ± SD) 27.8 ± 9.2 31.0 ± 8.7 
Gender (% female) 77.0% 53.3% 
Ethnicity (% White) 97.3% 93.3% 
Country (% UK/Ireland) 96.0% 93.3% 
Education (% Higher Ed) 60.8% 53.3% 
FEV1% (mean ± SD) 61.7 ± 25.0 58.0 ± 21.0 
Lung transplant (% yes) 6.8% 7.7% 
 
3.3 PROCEDURE 
Recruitment was initiated via a message posted on the CF Trust discussion forum by a 
member of the CF Trust communications team. This linked to an information page 
describing the study to forum users. Notices were placed within the ‘teenage’ and ‘adult’ 
sections of the discussion forum. After 3 and 6 weeks, the researcher replied to the initial 
post to thank those who had already taken part, to encourage further participation and also to 
bring the notice to the top of the discussion area. In addition, 6 weeks after the original post 
on the CF Trust discussion forum, the communications team placed a recruitment notice  
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Table 3.3 Demographic and basic clinical information summary for full data sets 
Demographic N (%) Clinical N (%) 
Marital Status (N = 74)  Age at CF diagnosis (N = 74) 
 Single/never married 28 (37.8)  At birth 19 (25.7) 
 With a partner 25 (33.8)  <6 months old 18 (24.3) 
 Married/civil partnership 20 (27.0)  6 – 12 months old 10 (13.5) 
 Widowed 1 (1.4)  1 – 4 years old 13 (17.5) 
   5 – 11 years old 3 (4.1) 
Education (N = 74)   12 – 17 years old 3 (4.1) 
 Some secondary school or less 1 (1.3)  18 – 25 years old 3 (4.1) 
 GCSEs/O-levels 11 (14.9)  >25 years old 5 (6.7) 
 A/AS-levels 17 (22.9)   
 Other higher education 13 (17.6) CF Severity, No Transplant (FEV1%; N = 54) 
 University degree 21 (28.4)  Normal (FEV1% 90%) 6 (11.1) 
 Professional or postgraduate 11 (14.9)  Mild (70 – 89%) 13 (24.1) 
   Moderate (40 - 69%) 21 (38.9) 
Work Status (N = 61)   Severe (<40%) 14 (25.9) 
Working full- or part-time 32 (52.5)    
Not attending school or work due 
to health 
12 (19.7) 
CF Severity, Transplant (FEV1%; N = 4) 
Attending school 11 (18.0)  Normal (FEV1% 90%) 3 (75.0) 
Seeking work 2 (3.3)  Moderate (40 - 69%) 1 (25.0) 
Not working for other reasons 2 (3.3)   
Taking education courses at home 1 (1.6)   
 Full-time homemaker 1 (1.6)   
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on the CF Trust Facebook page followed by a repeat post from the researcher 2 weeks later. 
In total, the online survey was open for ten weeks.  
 
The information page contained a web-link to the online survey, hosted by Survey Monkey 
(www.surveymonkey.com). Participants self-selected themselves to take part in the research 
and were eligible if they were 16 years old or over and had a diagnosis of cystic fibrosis. 
Participants were asked to provide consent prior to completing the online survey. Those who 
chose not to consent were directed to the end of the survey and thanked for their time.  
3.4 MEASURES 
3.4.1 Cystic Fibrosis Questionnaire – Revised (CFQ-R) 
The CFQ-R (Bryon & Stramik, 2005; Quittner et al., 2002) is a measure of health-related 
quality of life (HRQoL) designed especially for people diagnosed with CF. The UK 
teen/adult version (for people aged 14 years old and above) was used in this instance. The 
measure consists of 50 items which assess HRQoL within 9 domains: physical functioning, 
health perceptions, vitality, respiratory symptoms, treatment burden, role functioning, 
emotional functioning and social functioning. The CFQ-R does not result in a single 
composite score. Previous research advocates for the consideration of four core domains 
when studying quality of life (Casier et al., 2011; Cella, 1998; Spilker, 1996), as a result, it 
was decided to include the CFQ-R subscales of physical functioning (eight items; e.g. ‘I 
have trouble recovering after physical effort’), emotional functioning (five items; e.g. ‘I 
often feel lonely’), role functioning (four items; e.g. ‘How often does CF get in the way of 
meeting your school, work, or personal goals?’) and social functioning (six items; e.g. ‘I get 
together with my friends a lot’). Each item on the CFQ-R is rated on a four point Likert 
scale. A standardised score ranging between 0 – 100 is obtained for each of the subscales, 
with higher scores indicating better functioning. The CFQ-R teen/adult version has been 
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shown to be well established, valid and reliable (Palermo et al., 2008). Cronbach’s alpha 
internal consistency analyses were carried out for each of the four subscales: physical α = 
.96, emotional α = .82, role α = .86 and social α = .63. 
3.4.2 Clinical Outcomes in Routine Evaluation – Outcome Measure 34 
The CORE-OM (Evans et al., 2000) is a self-report measure consisting of 34 items to assess 
psychological and emotional distress in terms of four sub-domains: subjective well-being, 
functioning, symptoms and risk. A total score is also calculated and is used throughout this 
study. Each item is rated on a four-point scale from 0 (not at all) to 4 (most or all of the 
time), with higher scores indicating greater difficulties. The measure has been shown to be 
reliable, valid and able to distinguish between clinical and non-clinical samples in the 
general population (Evans et al., 2002), primary care settings (Gilbody & Barkham, 2007) 
and patients with type 1 diabetes (Masding et al., 2011). In this instance, internal consistency 
tests of reliability revealed Cronbach’s alpha of .96. 
3.4.3 Rosenberg self-esteem scale (Rosenberg, 1965) 
This 10-item brief self-report questionnaire is designed to measure levels of global self-
esteem in adolescents and adults. Each item is rated on a four-point scale (strongly disagree, 
disagree, agree, strongly agree) and produces a total score ranging from 10 – 40. Higher 
scores represent higher levels of self-esteem. This measure of self-esteem has been used in 
chronic illness populations including samples of adults with CF (Abbott et al., 2000; Abbott 
et al., 2007; Ireys et al., 1994) and has been shown to have satisfactory psychometric 
properties (Sinclair et al., 2010). Internal consistency tests of reliability revealed a 
Cronbach’s alpha of .94. 
3.4.4 Demographic questionnaire 
General information was collected using a set of questions developed by the researcher in 
collaboration with two health colleagues. This included age, gender, occupation, diagnosis, 
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current physical health status (including most recent FEV1% predicted reading and lung 
transplant status) and frequency of discussion forum use. FEV1% predicted is a measure of 
lung function frequently used to classify severity of respiratory disease. Participants were 
asked how often they made use of the CF Trust discussion forum and/or Facebook page. 
They also indicated from a list of options, the things they used each site for. Where 
participants indicated that they used the CF Trust discussion forum, two open-ended 
questions asked what users liked most and least about the forum.  
3.5 DATA ANALYSIS 
3.5.1 Quantitative data 
Raw data were entered into SPSS version 17 where coding and total scores were calculated 
for each assessment measure. Scores for those participants who had fully completed the 
online survey (N = 74) were included in analyses. Kolmogorov-Smirnov statistical tests were 
carried out to determine the normality of data distribution for FEV1% predicted and each 
outcome measure variable. Normal distributions of data were found for FEV1% predicted (D 
= .95, p = .67); CORE total (D = .11, p = .32); Rosenberg self-esteem scale (D = .12, p = .26) 
and CFQ-R subscales of emotional (D = .11, p = .38), social (D = .09, p = .60) and role (D = 
.14, p = .11) functioning. The CFQ subscale scores for physical functioning were not 





                                                 
1
 The researcher explored the benefit of transforming data using a square-root function. This 
succeeded in distributing scores normally (D = 0.14, p = .11). However, as the transformed scores did 
not result in any differences in the significance of subsequent statistical analyses compared to when 
using raw scores, it was decided to use the raw data for ease of interpretation of findings. 
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3.5.1.1 Correlations and power analysis 
Correlations using Pearson product moment analyses were conducted between the following 
variables: physical health status (as measured by self-reported FEV1% predicted); CFQ-R 
physical, social, role and emotional functioning; CORE-OM total score; and Rosenberg self-
esteem scale total score. Consideration was given to removing data of those participants who 
had undergone a lung transplant prior to statistical analysis. Given the small number of 
participants for whom this was applicable (N = 5) and the fact that mean scores were not 
changed significantly when they were excluded, it was decided to include their data in 
subsequent analyses.  
 
Calculations were carried out using G*Power version 3.1.2 to establish the size of correlation 
which could be confidently detected for a sample size of 74, an alpha level of .05 and 
statistical power of 0.8. With a two-tailed hypothesis this revealed analysis could detect 
correlations of r = .31, a medium effect size (Cohen, 1988). 
3.5.1.2 Gender comparison 
Past research has suggested gender differences in quality of life and psychological well-
being scores in CF populations (e.g. Anderson, et al., 2001; Gee et al., 2003). In light of the 
unequal split of males and females within the study sample it was felt important to explore 
whether the overrepresentation of females had impacted on the mean levels of wellbeing and 
HRQoL in the present study. As a result, t-test comparisons of male and female mean scores 
on each outcome measure and FEV1% predicted were carried out. It was recognised that due 
to the small sample, these comparisons were unlikely to meet statistical power to detect 
small or medium effect sizes. However, it was felt that exploring this area of potential 
influence on data remained important in order to interpret findings and consider them against 
existing studies which include an equal split of males and females. 
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3.5.2 Online resource questions 
Data indicating how frequently participants used the CF Trust discussion forum and 
Facebook page were summarised using percentages. For the two open-ended questions, 
responses were collated and summarised on the basis of themes mentioned across the data 
set. Analysis of these questions was carried out for all available data whether or not 
standardised measures had been fully completed. 
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4 STUDY 1 RESULTS 
4.1 DESCRIPTIVE STATISTICS 
Table 4.1 presents the mean and standard deviation (SD) for each measure completed within 
the online survey.  
 
It can be seen that average scores on the CFQ-R subscales vary.  The lowest score was found 
for physical functioning (mean = 46.96, SD = 32.50) and the highest for role functioning 
(mean = 65.61, SD = 23.40). Mean scores of 57.30 (SD = 24.62) and 59.23 (SD = 20.38) 
were obtained for emotional and social functioning respectively. Self-esteem scores from the 
online survey produced a mean score of 29.89 (SD = 7.08). The mean score on the CORE-
OM 34 was 1.01 (SD = 0.72) and, when classified according to clinical thresholds, 29.7 per 
cent (N = 22) of participants reported clinical levels of symptoms.  
 
Table 4.1 Means and standard deviations of outcome measure scores by gender 
Mean scores (SD) 
Outcome measures 
Male Female Total 
FEV1% predicted 66.73 (26.9) 60.47 (24.6) 61.66 (25.0) 
Physical functioning 58.82 (37.6) 43.42 (30.3) 46.96 (32.5) 
Role functioning 71.57 (23.8) 63.73 (23.2) 65.61 (23.4) 
Emotional functioning** 71.76 (20.9) 52.98 (24.2) 57.30 (24.6) 
CFQ-R 
Social functioning** 70.59 (15.6) 55.85 (20.5) 59.23 (20.4) 
CORE-OM total score* 0.64 (0.5) 1.13 (0.7) 1.01 (0.7) 
Rosenberg self-esteem scale** 33.94 (5.1) 28.68 (7.2) 29.89 (7.1) 
* gender difference significant at the level of p<.05 
** gender difference significant at the level of p<.01 




Pearson product moment analyses were conducted to establish whether relationships existed 
between variables of disease severity (as measured by FEV1% predicted), HRQoL, mental 
health and self-esteem. The results of the correlation analyses are presented in Table 4.2. As 
would be expected, significant positive correlations were found between the four subscales 
of the CFQ-R. 
 
Correlations between CFQ-R subscales and CORE-OM total score were all negative, with 
lower quality of life scores associated with higher levels of mental health difficulty. 
Significant positive correlations between CFQ-R subscales and self-esteem scores were 
found, indicating that higher levels of self-esteem are related to better HRQoL. Higher self-
esteem scores were also associated with lower levels of mental health difficulty as shown by 
the negative correlation between the CORE-OM total and Rosenberg self-esteem scale 
scores. Lung functioning was seen to correlate positively with CFQ-R subscales of physical, 
role and social functioning. This suggests that those with better lung function experience 
better quality of life in these domains. The only non-significant correlations were found for 
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4.3 GENDER DIFFERENCES 
Exploratory two-tailed t-tests were carried out to compare scores of males (N = 17) and 
females (N = 57) on each of the outcome measures. Mean scores, standard deviations and 
significance can be found in Table 4.1. Females were found to score significantly lower than 
males on the CFQ-R domains of emotional functioning (t = 2.897, p = .005) and social 
functioning (t = 2.730; p = .008). Females were also seen to have lower levels of self-esteem 
(t = 2.813; p = .006) and higher total CORE-OM scores of mental health symptoms (t = 
2.534; p = .013). No significant gender differences in FEV1% predicted (t = 0.746; n.s.), 
physical functioning (t = 1.739; n.s.) or role functioning (t = 1.208; n.s.) were found. 
4.4 USE OF ONLINE RESOURCES 
The frequency with which participants made use of the CF Trust discussion forum and 
Facebook page varied (N = 85). Half of the participants (N = 44, 51.8 per cent) used only the 
discussion forum, 24.7 per cent (N = 21) used only the Facebook page, whilst a further 23.5 
per cent (N = 20) used both online resources. Frequency of visits to and posts made on the 
CF Trust discussion forum varied. Data were available for all but one of the participants who 
used the CF Trust forum (N = 63). Most forum users visited the site either everyday (N = 16, 
25 per cent) or 3 to 4 times per week (N = 28, 43.8 per cent). Smaller numbers of 
participants visited the site once a week (N = 7, 10.9 per cent), 2 to 3 times per month (N = 
8, 12.5 per cent) and once a month or less (N = 4, 6.3 per cent). Much less frequent were the 
amount of posts made on the discussion forums. The majority of users posted once a month 
or less (N = 25, 39.1 per cent), whilst fewer participants posted 2 to 3 times a month (N = 8, 
12.5 per cent), once a week (N = 9, 14.1 per cent), 3 to 4 times a week (N = 8, 12.5 per cent) 
and everyday (N = 3, 4.7 per cent). A proportion of forum users never posted on the site and 
chose to only read posts (N = 10, 15.6 per cent). 
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For those participants indicating usage of the discussion forum or Facebook page, indication 
was given as to the purposes for which these sites were used. These are presented in Table 
4.3. Seven participants also provided comments on their use of the online resources not 
included within the survey options; five people said they use the sites to help others and offer 
advice, one person signed up to support the site and one person used the site to find out about 
television appearances by people with CF. 
 
Table 4.3 Uses of discussion forum (N = 64) and Facebook page (N = 40) 




Find information about CF 62 (96.9%) 20 (50.0%) 
Find information about CF treatments 56 (87.5%) 13 (32.5%) 
Get health advice 48 (75%) 14 (35.5%) 
Pass the time when in hospital 26 (40.6%) 19 (47.5%) 
Keep in touch with CF friends 22 (34.4%) 15 (37.5%) 
Get advice about things other than CF 17 (26.6%) 10 (25.0%) 
Meet new people 15 (23.4%) 15 (37.5%) 
Find out about events 14 (21.9%) 18 (45.5%) 
Arrange fundraising events 11 (17.2%) 6 (15.0%) 
 
4.4.1 Open-ended questions 
Participants who indicated use of the CF Trust discussion forum were asked to comment on 
the things they liked a) most and b) least about the forum. A total of 62 and 56 participants, 
respectively, chose to comment. Themes of these comments are described below. 
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4.4.1.1 Things most liked about the CF Trust discussion forum (N = 62) 
Some aspects of the forum which people liked most were the shared experiences and 
understanding between forum members and the support that people offered on the site. Many 
people commented that they liked the availability of advice, information and opportunity to 
discuss CF generally and, more specifically, others’ experiences of treatment. A number of 
people commented that they liked meeting new people and that the forum helped to 
overcome the restrictions resulting from segregation policies. In addition, some users 
mentioned that they felt reassured that they were not alone in coping with CF and they 
valued having contact with other people who were ‘in the same boat’. A few participants 
mentioned that they felt the forum had a friendly atmosphere where people were honest 
about their opinions and feelings. Others appreciated the range of experiences that members 
had and felt there was a sense of community between the forum members. Finally, it was 
also mentioned that the site was well-monitored by the CF Trust moderators. 
4.4.1.2 Things liked least about the CF Trust discussion forum (N = 56) 
By far the most common feature which was liked least about the discussion forum was the 
occurrence of arguments and disagreements amongst members. Many people commented on 
this along with the occasional insensitivity, personal insults and lack of respect within some 
forum posts. However, a number of participants commented that these issues arose in 
everyday life and were a normal part of relationships. Others commented that they disliked 
the ‘cliques’ within the forum user group. Another common comment made by participants 
was the tendency for the forum to be negative in terms of some content and information 
which led people to feel lower in mood. This was highlighted in terms of posts being a 
reminder of the daily difficulties faced when coping with CF, the future progression of the 
disease and notifications of people who had died. A minority of participants commented that 
they felt the relevance of some topics should be more closely related to CF, that people often 
asked questions previously discussed on the board and that getting replies to posts can be 
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slower than other social networking websites (such as Facebook). A number of comments 
related less to the content of posts and more to the organisation of the discussion forum in 
general. Some felt that the moderation by the CF Trust could inhibit discussion or be heavy-
handed. Others would prefer if the forum was split into more defined discussion areas, that 
users had the option to send personal messages (not publicly visible) to others and that the 
forum was updated in its appearance. 
4.5 SUMMARY 
The results indicate that the participants have variable levels of HRQoL depending on 
domain. Lowest scores were obtained in physical functioning whilst highest functioning was 
seen in relation to roles. The sample seemed to have good levels of self-esteem despite their 
poor levels of physical functioning. Mental health symptoms were at clinical levels for 29.7 
per cent of the sample, with an average total score on the CORE-0M of 1.01. Significant 
correlations were revealed between measures of mental health, self-esteem and HRQoL 
indicating that better levels of HRQoL are related to higher levels of self-esteem and lower 
levels of mental health difficulty. Furthermore, females were seen to experience lower levels 
of emotional and social functioning, poorer self-esteem and higher levels of mental health 
difficulty compared to males.  
 
In relation to the use of online resources, participants used the CF Trust discussion forum 
and Facebook page to differing degrees with the majority of people visiting the discussion 
forum more than twice per week. Posting on the forum, however, was much less frequent, 
with most people posting only once a month. It seems that the two online resources provide 
CF patients with the opportunity to interact with and meet other people with CF without risks 
of cross-infection. In addition, the availability of information, advice, shared understanding 
and support appear to be valued aspects of the forum. Participants acknowledged that there 
could be difficulties in interactions similar to those which play out in non-virtual relationship 
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such as arguments and misunderstandings. Despite this, participants still reported a sense of 
community, support and solidarity with their fellow forum-users. 
 
This study has provided an insight into the levels of mental health difficulty, self-esteem and 
quality of life within this population along with their views on elements of the discussion 
forum which they like or dislike. The second study aims to explore the range of topics 
discussed and the way the forum is used through a qualitative thematic analysis of discussion 
forum posts. 
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5 STUDY 2 METHODS 
5.1 DESIGN 
This study aimed to systematically examine discussion posts made on an online discussion 
forum aimed at people whose lives are affected by CF. Qualitative data were collected from 
the forum retrospectively using a time period of one month. 
5.2 PROCEDURE 
Participants were recruited to take part in the study via Study 1. Usernames provided by 
participants were gathered and the first 25 users consenting to take part in the study were 
identified. All participants providing their username had consented for posts made over the 
preceding six months to be used in the research. However, due to the high response rate, it 
was decided to take a sample of data from the first 25 participants’ posts over a 4 week 
period. Posts made during the month preceding the first recruitment notice were collected 
and organised by author in chronological order. Eight of the 25 users had made no posts 
during the time period specified. Forum posts from the remaining 17 users were entered into 
a word processing document for thematic analysis. The final sample of forum data used in 
this study consisted of 404 posts across 171 discussion threads made by 17 different forum 
users. 
5.3 PARTICIPANTS 
A total of 55 participants supplied their CF Trust forum username to allow research to collect 
their forum posts for analysis. All participants were adults over the age of 16 years who had 
a diagnosis of CF. For the 17 participants whose data were used, their average age was 29.9 
years (SD = 7.8, range 20 to 48 years). The majority of users were female (N = 12, 70.6 per 
cent) and 2 (11.8 per cent) were known to have had a lung transplant. On average, the forum 
users had been a member of the CF Trust for 3.1 years (SD = 1.3, range 0.08 – 4.2 years). 
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5.4 DISCUSSION FORUM 
At the time of recruitment, the CF Trust discussion forum had a total of 4649 registered 
members and consisted of six discussion areas: CF teenagers, CF adults, parents and carers, 
partners of people with CF, fundraising forum and runners’ forum. The forum is open to the 
public and visitors to the site need not register in order to read threads. Within each 
discussion area, registered users may start a new topic of conversation by posting a comment 
or question. Other users may then respond with their own contributions, forming a discussion 
or ‘thread’. The CF Trust provide ‘house rules’ informing users of good practice on the 
discussion boards, including advising against disclosure of personally identifiable 
information, avoiding offensive posts and advertising. A group of administration staff and 
moderators oversee the use of the forum to ensure appropriate postings. They are able to lock 
threads to prevent further discussion on a topic or delete those which are inappropriate for 
the forum (e.g. spam messages or those deemed offensive). 
5.5 DATA ANALYSIS 
5.5.1 Qualitative data 
Once gathered from the CF Trust discussion forum, user posts were analysed using 
framework thematic analysis (Ritchie & Lewis, 2003). Choice of analysis approach was 
guided by two factors. Firstly, the primary aim of the study was to explore the topics under 
discussion on the forum rather than to provide a representation of the experience of forum 
users or analysis of their conversation per se. Secondly, the nature of data collection meant 
that all data was cross-sectional and collected prior to analysis and the researcher was unable 
to ask further questions to explore emergent themes. Thus, thematic analysis was felt more 
appropriate than a phenomenological or grounded theory methodology. More specifically, 
framework analysis was selected in order to provide a structured and transparent method to 
approach data analysis (Ritchie & Lewis, 2003; Smith & Firth, 2011). Although framework 
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analysis has been used in a relatively ‘top-down’ manner within applied policy research (e.g. 
Srivastava & Thomson, 2009), the original developers highlight that its use was intended to 
be dynamic and flexible (Ritchie & Lewis, 2003). The utility of framework analysis within 
healthcare research has become increasingly recognised in recent years (Smith & Firth, 
2011). Framework analysis involves moving through a number of stages including 
familiarisation, identifying a thematic framework, indexing, charting and mapping and 
interpretation (Ritchie & Lewis, 2003). Although these stages can be sequential, researchers 
benefit from moving forwards and backwards through each data stage in order to ensure that 
analysis remains close to the original data and misinterpretations are minimised (Ritchie & 
Lewis, 2003; Smith & Firth, 2011). Each phase of analysis will now be described. 
5.5.1.1 Data management and familiarisation 
All posts made by each consenting forum user were collected and arranged in chronological 
order. A subset of six participants’ posts were selected which were felt to present a varied 
range of discussion topics and posts. The researcher became familiar with the content of the 
posts by reading and re-reading.  
5.5.1.2 Identifying a thematic framework and indexing 
During the latter stages of familiarisation, the researcher began to note recurring topics of 
discussion present in the data. A further reading of the subset of posts was carried out with 
the specific purpose of building a list of the topics covered and the characteristics noticed 
within them (e.g. whether posts were seeking information, providing advice, sharing 
experiences etc.). Once it was felt that the data was adequately represented by the identified 
categories, the researcher wrote each of these on a separate piece of paper. This allowed 
categories to be moved freely and for different organisational groups to be explored. With 
frequent referencing back to the raw data, this process allowed the development of the initial 
indexing framework which would be used to code the remaining data which was not 
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included in the initial subset for familiarisation. An example of how the themes were derived 
from the original data is presented in Table 5.1. At this stage, it was important for the 
framework to remain flexible to ensure that when approaching the whole data set, categories 
not fitting well into the initial framework could be logged and revisions made. A copy of the 
initial indexing framework is included in Appendix G. 
 
The indexing phase involved applying the thematic framework to the whole data set. Each 
sentence, phrase or paragraph of each post was considered in turn and coded in accordance 
with the indexing framework. Throughout this process, the indexing framework was revised 
in order to capture new topics not previously identified within the familiarisation subset of 
posts. A copy of the final indexing framework can be found in Appendix H. 
5.5.1.3 Charting and mapping 
Thematic charts, also known as matrices, were created to enable a view of the whole data set 
using computerised spreadsheet software. Seven charts, one for each main theme were 
developed to include key words, quotations and summarised content for each participant 
within each theme sub-topic. Each index category was represented by a column and each 
participant represented by a separate row. This presentation method allowed for comparison 
across cases (i.e. forum users) to ensure consistency within and distinction between themes. 
Reviewing data in this way also brought attention to topics which could be merged together 
into a broader category whilst remaining true to the raw data. 
5.5.1.4 Interpretation 
The final stage of framework analysis was to develop a way of summarising and interpreting 
data in terms of identified patterns, concepts and explanations. The matrices of data enabled 
the researcher to gain an overview of themes, tone of posts and individual user narratives. 
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Table 5.1 Example process for arriving at a theme 
Participant Post extract 
Preliminary 
thoughts 
Category Initial theme 
‘I usually have a well 
behaved port and have got 
used to its funny little 
ways and how it usually 
behaves.’ 





‘Same goes for explaining 
to friends why I need IVs 
when I outwardly don't 
look that ill. I love my 
friends dearly, but there's 
lots they don't 
understand.’ 
Explaining to 






to hide coughing 
symptoms. 
Hiding 
symptoms of CF 
Female  
25 years old ‘I usually hide [my cough] 
quite well though, I have 
breathing techniques I use 
to take it away unless I'm 
really bad. Then when I 
do have a normal 
coughing fit in public, 
everyone starts to panic 
and fuss over me, not 
accepting the "this is 
normal, please leave me 












Key products of this phase included the creation of a data display diagram to visually 
represent the key themes and their inter-relations. Displaying data in this manner aids 
researchers in understanding, analysing and communicating to others the themes and patterns 
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which have emerged throughout the analysis process (Miles & Huberman, 1994; Ritchie & 
Lewis, 2003). In addition to this visual representation of data, a written explanation of 
themes and results of the analysis was also developed. 
5.5.1.5 Software 
Qualitative analysis was aided by using Nvivo 8, a computer programme designed by QSR 
International (2008) to help organise and track the analysis process. Once imported into 
Nvivo, codes were assigned to text in line with the indexing framework developed during the 
earlier stages. Computerised spreadsheet software was used to create tables during the 
charting process to illustrate themes and case-examples from the qualitative data. 
5.5.1.6 Ensuring validity and quality in qualitative research  
In order to maintain validity and rigour within the qualitative analysis process, a number of 
strategies were used. The researcher aimed to carry out analysis in a transparent and 
reflexive manner to ensure that the processes followed were clear and considered (Lewis & 
Ritchie, 2003; Yardley, 2008). Although it was not possible to obtain a full second opinion 
on applying codes to data, two researchers were consulted throughout the analysis process. 
Discussion was carried out around the data, emerging themes, potential refinements, 
development of data displays and ensuring consistency and coherence throughout the 
analysis (Yardley, 2008). A reflective approach was taken during all phases of research in 
order to remain open to new themes as well as potential researcher influences and contextual 
factors which may have impacted on the analysis process (Lewis & Ritchie, 2003; Yardley, 
2008). Finally, whilst creating the data display and exploring inter-relations between themes, 
the researcher made efforts to identify cases within the data which provided contradictory 
examples to the developing understanding. 
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6 STUDY 2 RESULTS 
Six key themes were identified from the analysis process to encompass the index topics 
present within the forum post data: regular or daily CF treatment; hospital experiences and 
procedures; changes in health and progression of illness; daily living and occupation; 
psychosocial processes and issues; and the future. A seventh set of index categories were 
also grouped together which identified the tone and nature of the post, for example, whether 
the author was seeking information, advice and sharing experiences or giving empathy, 
encouragement or reassurance. Figure 6.1 visually represents the main thematic groups and 
their sub-topics. It also includes reference to the general tone of posts across themes. In the 
following sections, each key theme, the tone of forum posts and comment on the individual 
users’ narratives running through the posts will be described.  
6.1 REGULAR OR DAILY CF TREATMENT 
The forum posts revealed regular discussion about aspects of routine CF treatment and its 
considerable demands on patients’ time and effort. 
 
P1, 25 year old female: 
Just staying well and maintaining my health takes hours of treatment a day, a 
lot of energy and focus and the help from everyone around me. 
 
Posts in this theme covered topics of oral and intravenous antibiotics, nebulisers, 
physiotherapy, diet and digestive enzymes. Some users sought clarification on dosage, 
timings of treatment, how medications worked or the different types of treatments available. 
Other users shared their own experiences, provided information or suggested advice. A 
number of threads introduced the pros and cons of particular types of treatment, for example 
providing explanation of different physiotherapy devices or sharing experiences of different  
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concentrations of hypertonic-saline (a solution inhaled to help mobilise mucus prior to 
physiotherapy). Included in the ‘cons’ of treatments was the discussion of side-effects from 
some medications, such as steroids or specific antibiotics. 
 
Four participants made reference to the difficulties of fitting treatments into everyday life, 
with recognition that treatments were occasionally missed.  
 
P1, 25 year old female: 
I always get up 2 hours before I leave the house so I have time to neb, physio, 
shower, get dressed and eat. Sometimes I don’t fit in the eating bit so grab 
something as I’m leaving or pay a quick visit to a shop. This morning though 
had to leave at 6.30 and woke at 5.45 so I’ve missed physio and neb and food. 
 
P11, 36 year old female: 
I totally understand where you[‘re] coming from. I have to get up at 6am just 
so I can drop my son and his m8s in to school. 
 
Amongst discussions about CF treatment there was an emphasis on the importance of 
adhering to particular treatments or associated monitoring procedures. Some posts used 
empathy, shared experiences and offered advice in a gentle manner, whilst others appeared 
more blunt in their approach. Multiple posts focussed on the use of one particular antibiotic, 
Tobramycin (‘Tobi’ or ‘Tobra’).  If blood levels of this drug are not carefully monitored, 
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P9, 27 year old female: 
I’m also not surprised that they won’t give you tobra if you wont let 
them take bloods. It would have been highly irresponsible for them to do 
so. 
 
P8, 27 year old female: 
Giving blood is not a big deal, yes it’s a pain, and it’s even more 
annoying when they miss, hit and pull out because of nerves, take the 
wrong vials, lose it or do the wrong test. But it’s still necessary. I’m 
assuming you have a port if you hate needles this much? 
 
Other post emphasised the importance of adherence to dietary recommendations after lung 
transplantation to minimise the risk of becoming ill. 
 
P13, 48 year old male: 
Any normal person will get a mild case of the runs. A person on 
immunosuppressants will get a very bad case of the runs, and in a 
couple of hours the bacteria will rip through their system and kill them. 
 
In contrast to the posts highlighting the more serious notes about CF treatment, some forum 
users chose a lighter, more humorous way to comment on treatment. One example of this 
provided a parody description of a physiotherapy device known as the ‘vest’ which vibrates 
to help mobilise mucus in the lungs during chest physiotherapy.  
 
P5, 32 year old male: 
Want to improve your physio? Maybe you’ve even thought about buying 
the VEST? Don’t! [P5] has a better, cheaper and ultimately more 
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satisfying idea. Instead of buying ‘the vest’, a very costly device, why 
not selotape a kitten to the front and back of your chest? Get the kittens 
to purr and you have your own cheap vest. 
 
This post was received well by other forum users and potentially acted to provide some 
comic-relief from discussion around the more serious topics of treatment adherence and side-
effects. 
6.2 HOSPITAL EXPERIENCES AND PROCEDURES 
Topics falling within this second theme centred around two areas: a) the experiences of 
inpatient admissions and hospital clinic visits and b) medical procedures which are not part 
of routine daily CF treatment.  
6.2.1 Hospital experiences  
Forum users discussed different CF units, their available facilities (for example, internet or 
mobile phone signal), the way clinics are run, segregation and infection-control policies. 
Posts outlined the resources available at and characteristics of particular units and offered 
reassurance to people seeking support prior to admission. 
 
P9, 27 year old female: 
Sorry to hear you have to go in, but you’ll be glad to hear the new ward 
is really very very good. The staff are friendly and helpful. The rooms 
are ensuite with Digital TV and free internet… The ward has it’s own 
kitchen and chefs… There is an exercise room with a TV… Take the 
chance to have a little rest and be waited upon! 
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Infection control strategies at different CF units were discussed alongside sharing views on 
segregation policies and their impact on cross-infection. Participants seemed to acknowledge 
that segregation was part and parcel of CF treatment and generally spoke positively about its 
contribution to reducing the likelihood of cross-infection and development of drug-resistant 
strains of infections. However, the difficulties with segregation were acknowledged, 
particularly for families where more than one child has CF or where patients with specific 
strains of infection were uncertain about being allowed access to new CF unit facilities. 
Personal viewpoints about segregation were voiced; some users suggested that everyone with 
CF had a duty to the wider CF community to prevent cross-infection and others indicated 
that their decisions to limit contact with other CF suffers were for their own health. 
 
P13, 48 year old male: 
If its just a very few couples and people from the same family infecting 
each other then that is bad for them, but not too bad for the CF 
community as a whole. But if I met a person with Cepacia, then met you, 
then we both went on to meet other pwcf (people with CF), then lots of 
people would end up with Cepacia. And if we are all being careless and 
meeting up, then that is bad for everybody. 
 
P17, 24 year old male: 
Ultimately we all have to make our own decisions. My decision is to 
keep away from you all – for my sake and yours :D 
 
6.2.2 Medical procedures 
The data set indicated a frequent exchange of knowledge and experiences between CF 
patients regarding medical procedures such as having a portacath (‘port’) fitted, having a 
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bronchoscopy or the addition of new tests to CF clinic visits. Advice was also provided to 
parents of children with suspected CF regarding the different diagnostic procedures, their 
limitations and range of outcomes. Some participants were seen to seek support and 
reassurance for their anxiety about upcoming procedures and to gain insight into the 
experiences of others who had similar procedures. Fellow forum users provided this, along 
with tips for coping with procedures, descriptions of personal experiences and, on one 
occasion, photographs of a port to help allay others’ fears. 
 
P7, 28 year old female: 
I decided to have my port fitted last September and actually had it done 
4 weeks ago. It looks ok and doesn’t show as much as I thought it would 
as I am skinny… I am more than happy to email you some pics… 
 
Skills of health staff were mentioned in relation to general CF care and specific medical 
procedures. Experiences of health staff skills were discussed in the context of inpatient stays 
and receiving routine blood tests. Participants expressed frustration at repeated failed 
attempts at inserting cannulas or taking blood, at times when procedures needed to be 
repeated and at the lack of CF-specific knowledge and experience of some staff.  
 
P1, 25 year old female: 
I have one vein that always bleeds, but it’s right next to a knuckle and it 
really really hurts, but not everyone will use that vein as they prefer to 
attempt the non-existent veins in my arms 50 times first, which hurts a 
lot more. 
 
Forum users shared their own experiences and provided support for others in relation to bad 
experiences. Some users acknowledged that mistakes are sometimes unavoidable and that 
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repeated tests or procedures were frequent in CF care. Users identified with others’ 
experiences through sharing similar stories of frustration or the use of humour. 
 
P5, 32 year old male: 
Getting jabbed a billion times is all part of the territory with CF… tad 
annoying... 
 
P8, 26 year old female: 
I was sedated by an inexperienced doctor and merry hell broke loose 
with my diabetes, I was LOW and boy was I craaaanky. 
 
6.3 CHANGES IN HEALTH AND PROGRESSION OF ILLNESS 
In addition to discussing CF treatment and associated medical procedures, there were many 
topics noted which addressed changes in health over time. Forum posts mentioning such 
changes (for better or worse), physical development and growth and lung transplant were 
encompassed by this theme.  
6.3.1 Changes in health 
Participants discussed and shared experiences of fluctuations in health and complications 
such as CF related diabetes (CFRD), respiratory infections, bleeds in the lungs and swine flu. 
Users who reported their health to be at a lower level often mentioned being admitted more 
frequently to hospital and receiving more treatment. Those who were experiencing health 
difficulties sought advice and alternative opinions on potential causes of exacerbations, 
avenues for treatment and support in coping with worsening symptoms. Information was 
provided by some participants on common complications which may develop over time in 
people with CF, for example CFRD, or the contraction of aggressive and hard-to-treat 
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infections such as pseudomonas or aspergillus. A particular user shared his extensive 
experiences of embolisation (‘embo’) procedures, which are used to treat bleeds into the 
lungs, and the continual battle for maintaining health. 
 
P5, 32 year old male: 
My bleeding has really slowed due to embos, went for a good couple of 
months without a bleed recently… It can be annoying bleeding, but 
recently I’ve found it especially annoying because it creates an 
environment for infection and therefore you feel you are constantly 
battling a light infection and trying to stave off IVs. 
 
In terms of short-term aggravation of symptoms, some participants mentioned the topic of 
smoking. Users expressed anger towards members of the public who ignored ‘no smoking’ 
signs whilst others warned fellow forum users of the health consequences of smoking when 
diagnosed with CF. A minority of posts mentioned their current good health despite some 
decline since childhood, reporting that they felt lucky to be doing well. 
6.3.2 Physical development and growth 
Physical development and growth topics were included in a number of posts. Advice was 
sought about typical growth patterns, i.e. if later growth spurts occurred for people with CF 
and expressing concerns about being shorter in stature than peers. Other users sought advice 
or shared their concerns about menstruation and the affects that hormones had on the ability 
to cope with CF treatment.   
 
P12, 23 year old female: 
I was still slightly concerned about my height and seemed to pretty 
much hit my final height… age 12 and am 4ft 10… my paediatric CF dr 
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predicted my height etc based on other members of the family and 
patterns in my own growth etc. My Gran was 4ft 11, mum is 5ft 2 so 
really my height isn’t bad for my family… 
 
6.3.3 Lung transplant 
Lung transplant was a topic which arose in relation to several main themes – CF treatment, 
medical procedures and the future. It was felt that, in light of lung transplant ordinarily being 
suggested at a point of particularly poor health and the fact that it can lead to dramatic 
changes in respiratory function, this topic was best represented alongside other topics related 
to changing health and disease progression. Discussions around transplant varied in terms of 
the position of the participant. Some were coming to terms with the suggestion of lung 
transplant by their team or seeking information on the transplant process.  
 
P15, 20 year old female: 
I think it’s also the fact I spent half of last year on IV’s including quite a 
few admissions to keep me at that lung function which has made them 
suggest transplant. In my head I think I’m too well at the moment 
anyway, it’s just the fact I know it will have to happen in the not too 
distant future. 
 
Other users shared experiences of being post-transplant, provided information on aspects of 
the transplant process and discussed practical changes or dilemmas they currently faced, for 
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P16, 28 year old female, post-transplant: 
I have decided that it’s time for me to look for a job in my degree 
[subject area]… My question is should I mention the whole transplant 
thing? Would some people see it as a negative thing when hiring? I feel 
like I need to mention it because it explains why I’m in an office job… 
 
Ok things I’ve been told I can’t eat that pop into my head right now – 
sushi, smoked salmon, rare meats, pate, tiramisu (sp?), some cheeses, 
natural yoghurt, soft ice cream, grapefruit. 
 
The presence of several people on the forum who had undergone successful lung transplant 
led to multiple posts of congratulation and well-wishing. However, not all forum members 
were so fortunate and members posted their memories and condolences for those who had 
lost their battle at some point on the transplant journey. One forum user shared a 
conversation he had with a fellow CF sufferer who was awaiting transplant and who later 
died: 
 
P5, 32 year old male: 
I was speaking to him last week about transplant and how he felt about 
it. I asked him, as it was one of my greatest concerns about transplant, 
whether he feared dying. He said he didn’t fear it, he was more worried 
about the people he would leave behind. It’s nice knowing he wasn’t 
scared or worried about what could happen. 
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6.4 DAILY LIVING AND OCCUPATION 
Forum users frequently had discussions around issues of everyday living and occupation. 
Most topics within this cluster were discussed in the context of CF with specific references 
to education, employment, Disability Living Allowance (DLA) and benefits, travel or living 
abroad and fitness and running. Other topics within this group which did not include direct 
discussion about the impact of CF included fundraising, past-times and hobbies, non-CF 
health topics and miscellaneous questions not related to CF.  
6.4.1 Education and employment 
Participants discussed their varied experiences of school and university, special 
arrangements that were provided for them during exams and how they felt their CF impacted 
on their education. Some users expressed their ambivalence about accepting special exam 
conditions as they wanted to be treated the same as their peers but were conscious that 
coughing during exams could disturb other students. A number of participants exchanged 
memories from school and university, some positive, some negative and some with a twist of 
humour: 
 
P5, 32 year old male: 
I regularly had coughing fits during lectures and the lecturer would 
stop the lecture to see if I was alive. I often couldn’t speak, so just gave 
the thumbs up, it became a running joke… in a good way. 
 
Advice was provided to parents in supporting their child with CF to make realistic decisions 
about their education and career path. Patients with CF shared their employment status, 
reasons for choosing their respective careers and the influence their health played in career 
decisions. Additional common topics pertinent to those seeking work or considering career 
options were: the disclosure of CF diagnosis to potential employers and explaining gaps in 
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employment due to ill health. Forum users contributed their personal opinions on when they 
felt was the most appropriate time to disclose diagnosis and offered advice to those who 
were currently making decisions about this. Participants also discussed whether it would be 
detrimental to gaining employment if they were to disclose true reasons for gaps in their CV. 
Some users advocated being upfront about this, whilst others felt this would decrease the 
likelihood of being offered employment and that an alternative reason for gaps, if available, 
should be given instead. 
 
P17, 24 year old male: 
I never mention CF at interview – I agree with [another forum user] 
that it’s expecting too much of an average manager to figure out the 
implications. I’ve never actually been asked any health questions at 
interview anyway so its not like I’ve felt that I was evading the question. 
 
6.4.2 Disability Living Allowance (DLA) and benefits 
Participants contributed to a number of discussions about benefits and DLA. Some posts 
sought information about the types of benefits people with CF may be entitled to and the best 
ways to explain the nature of CF when filling in application forms. Complementing these 
posts were others which shared experiences of receiving benefits in the context of personal 
circumstances and clarified eligibility for the different types of benefits. Furthermore, 
comments were posted which explained to others that benefits and carer allowances made it 
possible to live independently from parents despite considerable health needs. An area of 
concern for people with CF raised within posts about DLA was the government changes in 
DLA assessment. Links were provided to external websites which outlined the move to 
‘capability assessment’ and these were followed by discussion of worries that the new 
assessment would not adequately account for CF and its impact on patients. 
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6.4.3 Travel and healthcare abroad 
Considerable discussion was noted around the topic of travel abroad. Participants sought 
advice on travel insurance and the logistics of travelling with CF, such as how to keep 
medications cool during transit or arranging oxygen to be accessed at destinations abroad if 
required. Forum users offered their own experiences and provided advice on these topics. 
Some posts indicated the importance of being honest when getting travel insurance to ensure 
that potential health needs are fully covered if something were to go wrong whilst away from 
home.  
 
P13, 48 year old male: 
I think the thing to declare is ‘post transplant (as the result of cystic 
fibrosis)’… If you don’t inform the insurers then the premiums you paid 
will be worthless and you could end up with the sort of expenses that 
bankrupt people. 
 
In addition to advice and information about holidays, discussions were also centred on living 
abroad and the CF healthcare available in other countries such as France, Denmark, Sweden 
and Australia. Participants shared links to appropriate websites and information they had 
found when considering a move abroad themselves.  
6.4.4 Other topics 
In addition to the key issues outlined above, data falling within this theme covered topics of 
fundraising, fitness and running, hobbies, non-CF health and non-CF general issues. These 
posts included discussion about how to organise and advertise fundraising events and sharing 
training advice to prepare for running events, such as half and full marathons. There were 
also more general discussions around shared hobbies or preferred pastimes such as going to 
the theatre or computer games. Some participants sought information and advice on non-CF 
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health issues including migraines, HIV and dental advice. Other unrelated general issues 
were also discussed, such as home heating systems and ideas for birthday celebrations.  
6.5 PSYCHOSOCIAL PROCESSES AND ISSUES 
The fifth main theme which emerged from the forum post data concerned psychosocial 
issues. Forum post contents fell into several sub-topic domains consisting of: adjustment and 
transition, interpersonal relationships, emotions, coping, body image and weight and social 
support. 
6.5.1 Adjustment and transitions 
Participants made reference to adjustments and transitions with regard to a range of topics. 
Some posts focused on practical adjustments such as getting used to new treatment methods 
or procedures, for example having a portacath or using oxygen at home. Other participants 
shared their experiences of adjusting to changes in health: either coming to terms with the 
suggestion of having a lung transplant or adjusting to life post-transplant. Transitions tended 
to be mentioned in the context of moving from paediatric to adult services or when 
discussing transition of adolescents to take more responsibility for their own treatment. 
Participants provided empathy and reassurance, shared personal experiences of transitions 
and gave support to other forum users facing similar stages in life. 
 
P13, 48 year old male: 
Of course you’re scared, and there’s nothing selfish about it! You know 
the paediatric team, you know how good they are, and you know you 
can trust them! You can’t say the same about the adult team. You don’t 
know them… It sounds like your son is beginning to take control and 
responsibility for his treatment. This is a very encouraging sign. 
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6.5.2 Interpersonal relationships 
Posts falling into this category introduced some interesting insights into the complexities of 
friendships for people with CF. Participants reflected on feeling different to their peers and 
having a hidden illness. One of the giveaway signs of CF for which concern was expressed 
was in coughing at school, university, work or in public. A number of forum users felt that 
the separate arrangements for exams whilst at school and university did not act to single-out 
people with CF because students with other difficulties, e.g. dyslexia, also required such 
additional support. Nevertheless, other participants expressed their concerns about being 
seen as different. Forum users explained their efforts to suppress coughing and hide visible 
signs of having CF, such as covering up a protruding stomach, portacath or cannula. Not 
only did this seem to be important for fitting in with peers, but also in hiding symptoms from 
family members or the CF team. Interestingly, two participants made reference to wanting to 
hide reminders of CF from themselves. 
 
P3, 25 year old female 
I think it’s undisputed that having [a port] makes IVs easier which 
sounds great. But like you my big concern is having it there, seeing it 
every day even if I’m well it would always be reminding me. 
 
P15, 20 year old female: 
I am so guilty of the “I’m fine!” response when anybody asks me how 
I’m doing. Even my CF team raise their eyebrows and tilt their heads 
when I say “I’m fine”… knowing that really means I’m terrible and 
need IV’s asap, they know me too well now! 
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Despite participants’ attempts and desire to hide their symptoms and the reality of CF from 
friends and family, threads on the forum indicated that they felt frustrated when it became 
apparent that friends did not understand what it meant or felt like to have CF. One participant 
shared her experience of telling her friends that she had been put on the lung transplant list: 
 
P15, 20 year old female: 
Recently transplant has been suggested by my clinic and I’ve been a bit 
emotional about it. Wanting them to understand so I had somebody to 
talk to about it, I got a couple of my close friends together and broke the 
news. During their reaction one of them, looking puzzled, said, “oh, 
well I kind of thought you were always on the transplant list anyway?!” 
to which the others nodded and agreed. 
 
Similarly, an older participant who had children shared her experience of other mothers 
when arriving at the school gates. 
 
P11, 36 year old female: 
…they smile and shake their ignorant heads. While I’m rushing around 
in the morning like a coughing, spluttering banshee they are sipping 
their coffee having a fag. 
 
6.5.3 Emotions, coping and psychology services 
Many emotions were expressed across the forum posts in a number of contexts. As would be 
naturally expected, anxiety and fear were commonly reported when discussing decisions 
about trying new treatments, upcoming procedures or when adjusting to changes in health. 
Low mood was mentioned by two participants who described identifying with other CF 
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sufferers in magazine articles or films which acted as a reminder of the potential trajectory of 
CF in the future. Anger was mentioned in a number of posts in relation to smokers, 
especially the fact that they were voluntarily damaging their lungs, that they may receive 
lung transplants instead of someone with CF or that smokers’ lungs may be used for 
transplant into someone with CF. 
 
In relation to coping with the realities of having CF, the demanding treatment regime and 
accompanying emotions, posts pointed readers in the direction of available psychology or 
self-help services and also suggested possible ways of coping. Some posts focussed on 
providing practical advice such as becoming as educated as possible about CF, seeking 
support from the CF health team and making treatment part of a habitual, daily routine. 
Strategies for coping with emotional aspects of CF were also offered, for example, remaining 
realistic in expectations, accepting personal limitations, trying to stay positive and hoping for 
advances in medical science. Some users shared their own experiences of having difficulties 
coping in the past and the detrimental effects of focussing on the worst case scenario. 
 
P13, 48 year old male: 
When I was 17, I felt very similar… I assumed there was no reason to 
make plans or get married, and that having kids was the most dumb 
thing I could think of. It turns out that assuming I was going to die was 
the mistake – the safe mistake, the sensible mistake, but still a BIG 
mistake. 
 
6.5.4 Body image and weight 
Although attempts were made to hide visible indicators of CF, one common CF 
characteristic discussed on the forum was not possible to hide: being small in size compared 
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to peers. Although some participants offered reassurance that growth spurts tended to occur 
later on for people with CF, some forum users found their appearance frustrating. 
Participants were able to vent their annoyances through sharing experiences of being asked 
for ID when going to see films, buying alcohol or being teased by work colleagues. 
 
P12, 23 year old female: 
The biggest guy at work wanted to put me on the top shelf in a cupboard 
just ‘cause he could. 
 
In contrast to the annoyances expressed on the forum about fluctuating weight and small size 
which were mentioned in a generally light-hearted way, some posts sought support from 
others with weight difficulties which had become health problems in themselves. Other 
forum users offered support and advice to those struggling to put on weight and those who 
were fearful of gaining weight. 
6.5.5 Social support 
Across many posts and themes, it was noted that empathy, reassurance and encouragement 
were frequently used to support fellow users at times of difficulty. Many posts centred on 
wishing people well, sending congratulations or wishing others a happy birthday. However, 
there were also numerous messages of sorrow, support and condolences for the family and 
friends of fellow forum users who had died. Despite the life-limiting nature of CF and the 
recognition of this by patients, some posts expressed the shock of losing a friend.  
 
P17, 24 year old male: 
Such a shock. Wasn’t expecting this at all. My thoughts go out to his 
family and many friends. 
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Many of the posts for those who have lost their lives to CF end with a touching phrase which 
seems to have been adopted by the forum to wish people well in death: 
 
P12, 23 year old female: 




Throughout the analysis process, themes emerged which seemed to make reference to the 
future. The index categories were felt best described in terms of fear and hope, pregnancy, 
fertility and parenting with CF, and NHS and political changes. 
6.6.1 Fear and hope 
A number of discussions expressed a fear of what the future may hold, particularly in terms 
of declining health and its consequences. Some feared the risks involved with having a 
transplant whereas others worried about the impact on daily living or their ability to cope 
with the process.  
 
P15, 20 year old female: 
I’ve not been able to sleep or function properly since Tues, just cannot 
think of anything but transplant and what the future holds now. 
 
In contrast to the posts expressing fear, there were also those which presented a more 
hopeful view of the future. These posts encompassed small specific hopes, e.g. for a 
portacath to continue working well, and larger hopes such as those for a long life in light of 
current good health or for medical advances to find a cure for CF. Some offered hope 
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through posting inspirational quotes whilst one forum member reassured others by using 
increasing life-expectancy statistics. 
 
P13, 48 year old male: 
It looks likely that even without breakthrough treatments, most kids 




6.6.2 Fertility, pregnancy and parenting with CF 
Several threads contained the sub-theme about future plans to have a family. Within these 
posts, participants mentioned fertility, the health consequences of pregnancy and coping with 
parenting with CF. Forum users sought information and advice on many aspects of becoming 
a mother and also contributed views about the difficulties which might be faced in the role of 
being a parent with CF. Members discussed their fears that future declines in health may 
mean that pregnancy was too risky. 
 
P12, 23 year old female: 
If I were to start on a downward spiral, I would have to reconsider 
having a family, but what also worries me is that I am well enough to 
have a family but that the stress of pregnancy and various other factors 
after birth etc could cause me to decline. 
 
Furthermore, a particularly emotive topic in relation to being a parent was raised; the 
morality of having children when the parent has CF. This brought numerous viewpoints and 
responses as people considered the potential impacts that CF may have on a person’s ability 
to cope with parenting roles. Some people reflected on their own childhood experiences of 
losing a parent to an illness and felt that doing this to a child was unfair. Others felt similarly 
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that being a parent with CF would prevent meeting children’s needs and lead to unbearable 
levels of guilt. Despite concerns, one participant felt that, providing her health was good 
enough, she would opt to have children but recognised that listening to the CF health team 
would ultimately guide her decisions. 
 
P3, 25 year old female: 
Is it really fair to knowingly bring a child into a world where they have 
to amuse themselves whilst you do treatments, where you are in and out 
of hospital, where they will probably lose a parent early in life?? 
 
P12, 23 year old female: 
If I am still well enough when the time is right then I will try and have a 
family. If I’m not… then I won’t, but it will be extremely hard on me 
emotionally. 
 
6.6.3 Future changes in the NHS and DLA 
The final sub-topic referencing the future was the discussion of governmental decisions 
which would impact on the provision of NHS health care and DLA benefits. Posts raised 
awareness of issues and provided web-links to further information about proposed and 
planned changes. A forum user raised concerns about changes to DLA and the impact these 
may have on people with CF. 
6.7 TONE OF POSTS AND PARTICIPANT NARRATIVES 
As mentioned within the section on social support, it was noted throughout analysis that 
posts generally had a supportive tone which provided empathy, reassurance and 
encouragement to other forum users. Those posts seeking support or information sometimes 
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covered difficult and emotive issues. The willingness of users to share personal experiences 
indicates a sense of safety within this online community. Numerous posts expressed thanks 
to other forum members for the provision of support, information and advice. 
 
Additional observations were made concerning the narratives of each forum user included in 
the study. It was evident through examination of the thematic matrices that some users’ posts 
reflected concerns or questions regarding particular issues which were pertinent for them at 
the time, such as lung transplant or declining health. On the other hand, a number of users 
tended to be the providers of advice, support and information to those seeking it. They 
shared their own experiences, educated others and provided web-links to external sources of 
further information. Some forum members appeared to be known amongst the community 
for having a wide knowledge base on particular subjects, and were called on for such 
information when needed. Additionally, it was noted that some members’ roles involved 
providing comic relief and to instigate light-hearted interactions. This perhaps acted to lift 
the general mood on the forum and provide an additional coping strategy for the realities of 
living with CF.  
6.8 SUMMARY 
Framework analysis of the forum posts revealed a diverse range of topics. Six main themes 
emerged from the indexed data which covered the daily and routine aspects of CF treatment, 
hospital experiences and medical procedures, daily living issues including employment and 
education, changes in health and disease progression, psychosocial processes and issues and 
coping with the future. The data illustrated the supportive nature of the posts and provided 
insight into the people who make up this community. Individuals shared experiences and 
offered advice, empathy, encouragement and reassurance. They provided information and 
support both for CF-related issues and those with no relation to their condition. Forum users 
were noted to use the resource differently over the period for which data was collected. 
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Some were seen to be seeking specific support in light of particular life-events or health 
changes, whereas others more consistently provided information, advice and shared their 
own experiences. The forum creates an opportunity for people with CF to interact without 
the risk of cross-infection. Participants are able to meet and discuss issues in a large 
community where others have first hand experience of what they are coping with. Due to 




The first study aimed to answer two primary research questions. These were to determine the 
levels of mental health symptoms, HRQoL and self-esteem in adults with cystic fibrosis who 
made use of an online discussion forum and whether any significant correlation existed 
between these variables. To the author’s knowledge, no previous studies have explored self-
esteem and its relationship with mental health and quality of life in adults with CF. The 
second study aimed to provide a qualitative insight into the topics arising on an online 
discussion forum for people whose lives are affected by CF. Although some studies have 
explored the use of specifically designed online support groups (Griffiths et al., 2009), there 
appears to be no representation of CF within this literature. The following sections provide 
discussion of the results from both studies within the context of current research literature. 
The clinical implications and limitations of the findings will also be addressed, along with 
consideration of directions for future research. 
7.1 MENTAL HEALTH, QUALITY OF LIFE AND SELF-ESTEEM 
Thirty per cent of the current sample fell above the clinical threshold of mental health 
symptoms when assessed using the CORE-OM. This percentage is higher than would be 
expected in the general population (Singleton et al., 2001) and is line with other published 
studies which conclude that adults with CF present with elevated levels of mental health 
difficulty (Cruz et al., 2009; Goldbeck et al., 2010; Havermans et al., 2008; Modi et al., 
2011; Riekert et al., 2007).  However, the finding is in contrast to the literature which 
provides evidence against elevated mental health difficulties in adults with CF compared to 
those without (Anderson et al., 2001; Pfeffer et al., 2003; Szyndler et al., 2005). In terms of 
self-esteem, the total mean score of 29.89 was comparable to scores presented in research by 
Abbott et al. (2000, 2007) who explained that in general, self-esteem for the CF groups was 




Although levels of mental health difficulty and self-esteem were described at similar levels 
to previous research, this was not the case for quality of life scores. There was notable 
variation between average sub-domain scores on the CFQ-R which ranged from 46.96 for 
physical functioning to 65.61 for role functioning. Scores for all four sub-domains were 
considerably lower than those reported in other studies (Casier et al., 2011; Sawicki et al., 
2011; Szyndler et al., 2005). There are a number of possible explanations for the lower 
levels of HRQoL in this study, one of which may be found in the differences between sample 
population characteristics compared to other studies. For example, both Casier et al.’s (2011) 
and Szyndler et al.’s (2005) sample involved much younger participants (mean age 18.4 and 
15.0 years old respectively) who had better lung function (mean FEV1% predicted scores of 
83.1 per cent and 72.4 per cent respectively). Although age has not been shown to influence 
quality of life and psychological well-being significantly (Havermans et al., 2008; Riekert et 
al., 2007), those with more severe disease are more likely to experience psychosocial 
difficulty and lower quality of life (Gee et al., 2003; Oxley & Webb, 2005; Pfeffer et al., 
2003). Participants included in the current study had a mean FEV1% predicted score of 61.7 
per cent, in the upper end of the moderate disease category. When looking at the proportion 
of participants falling within each category, the majority are within the moderate or severe 
category of disease (62 per cent). From this, it may be considered that the lower HRQoL 
scores across all domains may be partially due to the severity of disease in the current 
sample. However, this explanation does not hold true when comparing to the study by 
Sawicki et al. (2011). Their large sample of 631 adults with CF were of a similar mean age 
(26.9 years, SD 9.7) and severity (FEV1% 61.0, SD 23.0), yet mean scores for the four CFQ-
R domain scores were approximately 20 points higher: physical 67.9 (SD 27.4), role 81.1 
(SD 19.4), emotional 76.3 (SD 20.0) and social 71.6 (SD 17.9). In this case, an alternative 
contributory factor to the difference may be grounded in the unequal gender split and 




Prior research has established that females with CF tend to fair worse medically than males 
(Nick et al., 2010; Stephenson et al., 2011). Furthermore, psychological research has 
established a number of gender differences, for example, females have been shown to 
experience higher levels of anxiety and depression (Anderson, et al., 2001; Goldbeck et al., 
2010; Modi et al., 2011), poorer HRQoL (Arrington-Sanders et al., 2006; Gee et al., 2003) 
and lower self-esteem (Abbott et al., 2000; 2007). The current study supports these findings 
and presents data indicating that females experience considerably more difficulties in a 
number of areas of psychological functioning and HRQoL. The exploratory analyses 
conducted within Study 1 show that females scored significantly lower on measures of 
emotional functioning, social functioning and self-esteem and higher on presence of mental 
health symptoms. Recent papers have highlighted the complexity in the interrelationships 
between mental health, HRQoL and social functioning in males and females (Abbott, 2009; 
Brucefors et al., 2011). It seems that females experience lower levels of HRQoL and have 
more difficulty managing symptoms, both physical and psychological, than males (Abbott, 
2009). Additionally, females who perceive their situation as less manageable have greater 
difficulty with anxiety, depression and social dysfunction (Brucefors et al., 2011). Gender 
influences in CF are emerging to be a complex picture and it would be useful for future 
studies take a longitudinal approach to examine the impacts of physical health and 
psychosocial variables over time.  
 
It seems that the female dominated sample in the present study may be one possible 
explanation for the lower mean HRQoL scores compared to previous studies. However, it is 
also possible that low scores are a reflection of the particular sample recruited. It may be that 
those with poorer quality of life were particularly attracted to taking part in the study. 
Alternatively, online resources can provide a convenient and anonymous environment which 
is available for those with access to the internet regardless of health status and mobility. As 
Discussion 
 87 
such, it may be that forums are frequented more often by those who have more physical 
health restrictions or who are less able to engage with aspects of ‘real-life’ and therefore 
have poorer HRQoL. This would contribute to the lower levels of HRQoL reported within 
the current sample.  
7.2 CORRELATIONS BETWEEN VARIABLES 
Correlation analyses between outcome variables revealed that higher self-esteem was related 
to better mental health and that better HRQoL in all four domains. These findings are 
somewhat intuitive and the significant relationships between higher mental health difficulty 
and lower levels of quality of life in all domains, including social functioning, are consistent 
with the results of previous research in adolescents and adults with CF (Casier et al., 2011; 
Havermans et al., 2008; Quittner et al., 2008; Riekert et al., 2007; Szyndler et al., 2005). 
  
Less severe CF disease, as measured by higher FEV1% predicted scores, was associated with 
better physical, role and social functioning domains of quality of life. However, no 
significant relationship was found between FEV1% predicted and emotional functioning, 
mental health difficulty or self-esteem. FEV1% predicted is a clinical measure of lung 
functioning and, therefore, lower scores indicate more severe lung disease. It follows that 
those people with poorer lung functioning will have more limitations on their physical 
health, be less able to carry out some roles within families, relationships or employment and 
be less able to socialise with friends. 
 
There are few studies which have specifically considered the role of self-esteem in relation 
to mental health and HRQoL in the CF population. Two studies published by Abbott and 
colleagues (Abbott et al., 2000, 2007) considered self-esteem alongside body image and 
eating behaviours in adults with CF. Although prevalence of eating disorders was low, their 
studies indicated a relationship between poorer self-esteem, enteral tube feeds and lower 
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levels of body satisfaction. The current study indicates links between high levels of self-
esteem and better mental health and social functioning in adults with CF. This corresponds 
well with research from the general population highlighting the protective influence of self-
esteem on mental health and, when combined with supportive social circumstances, its 
positive influence on low mood and coping with serious physical illness (Mann et al., 2004).  
 
Of course, one of the difficulties in using correlation statistics is that causality cannot be 
inferred. Although there are clearly relationships between the variables of mental health, 
HRQoL and self-esteem, the influential impacts between them are still unclear and the 
temporal relationships cannot be deduced in this cross-sectional study. It may be that poorer 
quality of life due to declining physical health leads to increased mental health difficulty and 
subsequently results in reduced social functioning. Alternatively, it may be that people 
experiencing emotional difficulties may function less well socially and experience 
difficulties adhering to treatments which then impacts on disease status, physical health and 
HRQoL. A third possibility is that additional variables may be playing a key role in the 
relationship, for example acceptance (Casier et al., 2008, 2011) or coping strategies (Abbott 
et al., 2008). Casier et al.’s (2008, 2011) studies highlighted the role of acceptance in 
depressive symptoms over time, but found little influence over anxiety. They revealed that 
higher levels of acceptance of limitations imposed by physical disease are associated with 
better psychological functioning (Casier et al., 2008). Moreover, the influence of coping was 
explored by Abbott and colleagues who found that higher levels of optimism and taking a 
problem solving approach were associated with higher levels of HRQoL (Abbott et al., 
2008). Conversely, higher levels of distraction, or behavioural avoidance, were associated 
with lower levels of HRQoL (Abbott et al., 2008). 
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7.3 USE OF ONLINE FORUMS 
Exploration of the online discussion forum posts revealed a range of themes spanning a 
number of domains of life for people with CF. Participants frequently discussed elements of 
CF treatment, including those which occur on a daily or regular basis, procedures which are 
less frequent and those related to exacerbations in their condition. Posts were also used to 
express feelings about particular aspects of life with CF and its associated demands, 
frustrations and anxieties. Themes acknowledging the impacts of CF on education, 
employment and the future appeared within the forum posts and many comments reflected 
processes of adjustment to different stages of life and disease. The topics of conversation 
present within the analysis have similarities to those presented by three qualitative research 
projects based on interviews with CF patients which explore the experience of growing up 
with CF (Jessup & Parkinson, 2010), disclosure of CF diagnosis (Lowton, 2004) and the 
experience of undergoing lung transplant (Macdonald, 2006). 
 
Jessup and Parkinson’s (2010) study invited children and parents to explore their experience 
of living with CF in unstructured interviews. The authors’ phenomenological approach to 
data analysis revealed eight themes: fright, fear, fight, flight, familiarity, form, future and 
philosophy and these resonated with those revealed in the present study. Jessup and 
Parkinson’s (2010) participants explained the fright of exacerbations and changes in health, 
fear of their own mortality and what may happen in the future, including transition to adults 
services and the inevitable path that CF follows. Fight referred to the regimented daily 
treatment which is required to stave off deterioration in physical health but also the fight for 
a normal and accepted life within education, work and social circumstances. Related to this 
was the theme surrounding form which reflected participants’ feelings towards their own 
body and physical appearance (Jessup & Parkinson, 2010). Similarities to these themes can 
be found in the discussion forum post themes of daily CF treatment, progression of illness, 
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the future and psychosocial processes and issues.  More specifically, the sub-themes of fear 
of the future, feeling different, body image, transitions and adjustment arising from the 
forum data reflect those themes raised in Jessup and Parkinson’s (2010) study. Furthermore, 
similarities can be found with flight, described by the authors’ as physical flight to different 
CF centres, imagined situations of being ‘fine’ and a desire to be ‘anywhere but here’ 
(Jessup & Parkinson, 2010). Equivalent topics are found in the current study in terms of the 
discussions between forum users about moving abroad and differences in CF healthcare, and 
also the recognition that some participant often presented to others that they were ‘fine’.  
Finally, similarities were present to a lesser extent with Jessup and Parkinson’s (2010) theme 
of philosophy. This referred to the meanings and metaphors held by each family to cope with 
the reality of CF, such as, ‘That’s life’ or ‘It was meant to be. Just do it’ (Jessup & 
Parkinson, 2010). A minority of forum posts in the present study acknowledged that 
acceptance of CF and the realities it brings can help with coping but the use of metaphors or 
philosophies by participants did not emerge to same extent as in study by Jessup and 
Parkinson (2010). 
  
The two more specifically focussed qualitative studies by Lowton (2004) and Macdonald 
(2006) also contain parallel themes to those topics discussed on the CF Trust online forum. 
Macdonald’s (2006) study focussed on CF patients’ experiences of going through the lung 
transplant process and the emergent themes were described as displacement, disorder, life in 
limbo and readjustment to wellness. Displacement refered to the process of realising and 
accepting that health had deteriorated to the point of requiring a transplant. This was 
followed by disordered emotions consisting of fear and hope for the future. At this point, 
participants described a need for support from those around them and from people who had 
been through the same process. Waiting for the telephone call notifying of a transplant was a 
difficult time for patients, involving some false alarms and disappointed hopes. Once 
transplant had been successful, participants required a period of adjustment to their new 
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health status and mixed feelings of guilt and gratitude for received another person’s lungs 
(Macdonald, 2006). The themes described by Macdonald (2006) bear significant 
resemblance to the issues encapsulated by the themes of psychosocial processes and issues 
and progression of illness in the current study.  
 
Similarities seen with Lowton’s (2004) study are found within psychosocial issues but also 
in the themes of daily living and occupation and the future. This interview-based study 
focussed on exploring the experience of adults with CF in disclosing their diagnosis to 
others. The author described three different situations where disclosure may take place: low-, 
medium- and high-risk situations (Lowton, 2004). Disclosure within all these circumstances 
was influenced by the current health of participants, their physical appearance and self-
identity and participants made active choices whether or not to reveal their CF. Low-risk 
situations were those involving casual encounters or meeting acquaintances. The emphasis 
for participants here was mostly on concealment of diagnosis but with awareness that 
coughing symptoms may give the diagnosis away.  Medium-risk situations were those 
involving friends, where decisions to disclose their CF depended on the level of closeness 
and the perceived reaction of the other person. High-risk situations for disclosure were those 
involving potential partners or employers. Revelation of CF in each of these situations was 
considered as having the most significant impacts and potential consequences of all. CF 
would impact on the future of relationships due to the associated difficulties with fertility 
and the increased likelihood of an early death. In the case of employment, disclosure of CF 
at all stages of job application could have disadvantages (Lowton, 2004). All of these issues 
are represented within the discussion forum posts and it seems that forum users take the 
opportunity to discuss these issues with their CF peers.  
 
In addition to the discussion topic themes noted within the forum posts, two additional 
observations were made about the general atmosphere of the posts and the individual 
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narratives of participants. Firstly, the majority of posts provided support and encouragement, 
information, advice or sharing of personal experiences. Those who shared feelings, 
experiences or concerns seemed to do so in order to illustrate a particular difficulty they were 
themselves facing or to help reassure or identify with another user’s situation. Secondly, 
when examining posts of each individual user across themes, forum users seemed to seek or 
provide support differentially depending on their current needs and point of disease 
progression. Some of the information shared was of a personal nature and it would seem that 
participants felt that the forum was a safe place in which to reveal their difficulties and 
potential vulnerabilities. These observations suggest that a culture of sharing experiences and 
providing empathic responses has been built within this online community.  
 
In relation to the survey questions focussing on internet resource use, it seems that the 
themes emerging from qualitative analysis of posts are comparable to the responses given for 
how people use the CF Trust forum. The top three reasons for using the CF Trust forum were 
to 1) find information about CF (96.9 per cent), 2) find out information about CF treatments 
(87.5 per cent) and 3) get health advice (75.0 per cent). When asked to rate the reasons for 
using the CF Trust Facebook website, it became apparent that this site is used differently to 
the CF Trust discussion forum. The most commonly identified uses for the Facebook site 
were 1) find out information about CF (50.0 per cent), 2) pass the time when in hospital 
(47.5 per cent), and 3) find out about CF events (45.5 per cent). Although participants used 
both sites to find out information about CF, a smaller proportion of participants identified 
this as a reason they used the Facebook page. The differential use of the CF Trust forum and 
Facebook site may be due to their differing contexts. Facebook is a widely-used social 
networking site targeted at the general public, whereas the CF Trust discussion forum is 
targeted specifically at those people whose lives have been affected by CF. Therefore, people 
may visit the CF Trust discussion forum when they have more specific questions or needs 
concerning their CF which their wider social network may not be able to adequately answer 
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or fully understand. On the other hand, Facebook provides a wider social connection with a 
greater variety of options to pass the time, such as sharing photographs or arranging events. 
Discussing more serious CF-related concerns in the public forum provided by Facebook may 
not feel as comfortable or beneficial as interactions which take place on the CF Trust 
discussion forum. Moreover, the additional comments made by participants identified the 
value of having shared experiences and understanding with other forum members. It seemed 
to provide people with a way to interact with others with whom they identified and with 
whom it would not be possible to meet face-to-face. Furthermore, involvement in the CF 
Trust forum allowed people with CF to offer advice and support others with CF. 
 
When considering the aspects least liked about the CF Trust forum in comparison to the 
qualitative forum data analysis there were some differences. Survey participants frequently 
mentioned problems with arguments arising within forum threads or some users being 
insensitive, rude or antagonistic. However there was little representation of this within the 
forum posts which were analysed in Study 2. A handful of posts were noted to take a stance 
attempting to diffuse potential arguments but feelings of antagonism and hostility were not 
picked up as a key aspect of any posts per se. The lack of presence of arguments within the 
sample of posts used may be a result of the self-selecting sampling method. It is possible that 
research participants choosing to provide their username for inclusion within the qualitative 
aspect of the study were those users who made use of the forum more frequently or perhaps 
those who used it in a more positive manner. 
 
The results of the qualitative analysis and summaries of the survey questions relating to 
forum use reflect similar findings to those within the existing literature on the use of online 
discussion forums or internet support groups (ISGs) for physical illness and mental health 
difficulties. Research has suggested a negative correlation between higher levels of social 
support or functioning and mental health symptoms (Anderson et al., 2001; Burker et al., 
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2000; Casier et al., 2011; Havermans et al., 2008; Riekert et al., 2007; Szyndler et al., 2005) 
and recent papers have shown that online interactions can meet social support needs of some 
populations. The literature focussing on physical health conditions other than CF has 
illustrated similar characteristics of mutual support, advice and information sharing within a 
range of private, public and purposeful online environments: breast cancer, arthritis, 
fibromyalgia (van Uden-Kraan et al., 2008);  depression (Takahashi et al., 2009); polycystic 
ovary syndrome (Percy & Murray, 2010); and multiple diagnoses (Sanders, Rogers, Gardner, 
& Kennedy, 2011). To the author’s knowledge, the only study which specifically focuses on 
internet support group (ISG) for people with CF is that described in Barber’s (2008) thesis. 
This study investigated the impact of ISGs on patients with CF and found that patients’ 
social needs could be met via online relationships and that these helped to overcome 
restrictions of segregation policies. 
7.4 LIMITATIONS 
During the process of completing this project, a number of limitations came to the attention 
of the researcher. The author acknowledges that the use of self-selected sample may mean 
that data are not fully representative of the entire target population. The sample is likely to 
include those users who are the most frequent visitors to the discussion boards and those who 
were most willing to take part (van Uden-Kraan et al., 2008). The proportion of the forum 
users who chose not to participate may have felt that they did not have time to complete the 
survey or they may have been deterred by some aspect of the project, such as the inclusion of 
mental health measures or the use of their forum posts. Furthermore, it has been noted that 
more females take part in online research (Rhodes et al., 2003) and this was apparent within 
the current research.  
 
A second limitation is found within the demographic questionnaire. Participants were asked 
to report their most recent FEV1% predicted reading and the accuracy of this can not be 
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guaranteed. Some CF patients may have several months between clinic visits where lung 
function tests are carried out and their FEV1% reading may have changed since their last 
assessment. Also, saliency of the information may have played a role in remembering or 
knowing FEV1% predicted score. For example, some clinicians may only routinely tell 
patients the outcome of their lung function test if it markedly low or patients may more 
easily remember their reading if it is particularly low or high. In defence of this potential 
limitation, it was seen that the average lung function fell in the region of previous studies of 
CF patients drawn from clinical settings and not from online populations (Havermans et al., 
2008; Riekert et al., 2007; Sawicki et al., 2011).  
 
A third and final limitation is found within the online survey and choice of mental health 
measure. The CORE-OM 34 was selected for its consideration of a wide range of symptoms 
rather than a focus on only one subset of symptoms, e.g. depression or anxiety. However, 
many other studies within CF make use of the HADS, BDI or SCL-90-R and this makes 
direct comparisons with other studies more difficult. Despite this, the ability to present data 
in terms of the proportion of participants who scored above recommended clinical thresholds 
enabled some level of comparison with other studies. 
 
Although not considered a limitation per se, it is inevitable within qualitative methodologies 
that the researcher involved will bring her own approach and background to the data analysis 
process. Throughout all stages of the analysis, the researcher attempted to remain close to the 
original data and avoid abstract interpretations. Coming from a background of clinical 
psychology, it is possible that this had some influence on the themes identified and synthesis 
of the data. However, in using a structured framework approach to the analysis, it is felt that 
any bias would have been minimised (Ritchie & Lewis, 2003; Smith & Firth, 2011). 
Furthermore, the researcher remained reflective throughout the analysis process, paid 
attention to contradictory posts and contrasted themes identified within forum posts with 
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those from the qualitative comments made in the online survey and previous research (Mays 
& Pope, 2000). These factors, alongside using an explicit and transparent analytical process, 
are known to improve the quality of qualitative research (Baym, 2009; Mays & Pope, 2000; 
Miles & Huberman, 1994; Ritchie & Lewis, 2003). 
7.5 ETHICAL CONSIDERATION OF ONLINE RESEARCH 
When embarking on this study using online data, a number of ethical considerations were 
taken into account. There has been considerable debate in recent years regarding the privacy 
of information contained on websites (Kozinets, 2010; Sveningsson Elm, 2009). Some 
researchers take the stance that information within the public domain, which can be accessed 
freely and is not password-protected, can be used in research without seeking prior consent 
from the authors. However, another branch of thought takes a more conservative approach 
and acknowledges that online community members may assume some level of privacy even 
though forums are in public view (Sveningsson Elm, 2009). Similarly, some web-users may 
not fully appreciate the open availability of the information they post and may not expect 
posts to be used in research (Corbyn, 2008; Kozinets, 2010; Sveningsson Elm, 2009). In the 
context of this study it was felt that a conservative approach was most ethical in terms of the 
use of online discussion forum data. Forum data was collected only from those survey 
participants who provided their forum user names and who consented to take part in the 
study. All participants were provided with full information about how data would be used, 
including that direct quotes may appear in research summaries and articles. 
 
A second important aspect to consider when carrying out any type of psychological research 
is to ensure minimisation of harm. Rhodes et al. (2003) highlight the difficulties of offering 
support and identifying needs of participants when data is collected online as opposed to 
face-to-face. It has been suggested that providing contacts of supportive resources at the end 
of the research fails to be communicated to those participants who may exit the survey 
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before completion and subsequently miss the resource information. In order to remedy this 
problem, reference was made within the information sheet that participants may find some 
items within the survey distressing. If this was the case, participants were encouraged to talk 
with a member of their health team or general practitioner. At the end of the survey, 
participants were also provided with the contact details for a number of mental health and 
support resources should they require them. 
 
A third and final point which was considered within the design and execution of the project 
was the matter of anonymity and confidentiality of data. This issue has received a great deal 
of attention in recent summaries of the ethical practice in online research (Kozinets, 2010; 
Sveningsson Elm, 2009). In terms of the quantitative survey, this was hosted by 
SurveyMonkey and once the closing date of the study had passed, responses were 
downloaded and deleted from this website. No IP addresses were collected within the survey 
and, in order to keep survey responses anonymous, usernames were separated from survey 
data once downloaded. Participants were asked not to provide any personally identifiable 
information, such as real name, address or email. Those completing the online survey were 
asked to give their date of birth (in order to ascertain age and also to provide a method of 
checking whether participants had completed the survey multiple times). In respect of the 
qualitative study, participants were asked to provide their CF Trust forum username if 
consenting to take part in this section of the project and for their forum posts to be used in 
the research. The CF Trust provides guidance for using their forum and advises users not to 
reveal any personal information including postal address, telephone number or email 
address. However, it has been acknowledged in the internet research literature that members 
of online communities sometimes post information which links pseudonym usernames to 
real names or circumstances (Kozinets, 2010). Using direct quotes within written reports of 
internet research projects has the danger of revealing the identity of research participants as 
powerful internet search engines could locate the original posting and its author’s username. 
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As a consequence, the researcher felt that it was extremely important for participants to be 
informed that direct quotes may be used within the written reports and that they were aware 
that in consenting to take part in the study, direct quotes may be used. It was felt by the 
researcher that the information provided to participants and the inclusion of a consent 
question adequately addressed ethical considerations within this study. 
7.6 CLINICAL IMPLICATIONS 
Despite the ongoing debate about whether adults with CF experience elevated levels of 
mental health difficulty compared to the general population, the impacts of difficulties where 
they do occur can have wide-ranging implications for quality of life and treatment adherence 
(Cruz et al., 2009; Quittner et al., 2008). The Department of Health (2005) has recognised 
the importance of establishing peer support networks for people with long term conditions in 
order to help support self-management of illness. With the segregation policies in place for 
CF care, patients with CF are not able to do this face-to-face and, instead, have to utilise 
other technologies to build relationships with their CF peers. Online discussion forums and 
support groups present an opportunity for people with CF to access peer support and these 
resources are becoming more widely recognised as a viable option (Hasenecz, 2010).  
 
A recent report resulting from collaboration between the Scottish Government and the Long 
Term Conditions Alliance Scotland (2011) highlighted that people living with long term 
conditions may not be receiving enough emotional and psychological support. They 
recommend that health services work jointly with third sector organisations to help fill this 
gap and the use of online communities may be one way of doing this. More specifically, the 
recognition that adults with CF may have unmet psychosocial needs is increasing and 
recommendations for CF services include the provision of a clinical psychologist (Oxley & 




Research exploring the relative benefits of involvement in online support groups or 
communities is still in its infancy in terms of the CF population. However, there does appear 
to be some emerging support for a positive influence of online support on psychological 
wellbeing (Barber, 2008). Literature focussing on the experiences of people with other health 
conditions has shown mixed results. It seems that although some studies claim that 
involvement in online support groups leads to reduced depressive symptoms, the often poor 
quality of study designs, such as lack of a control condition or providing other potentially 
influential interventions at the same time, compromises the confidence in findings (Griffiths 
et al., 2009).  
 
The current project did not aim to assess the impact of involvement with an online 
community on mental health or quality of life. Instead, its focus was on finding out the 
mental health needs of this population and exploring the ways in which the discussion 
forums are used and the topics which arose. It was seen within this project that adults with 
CF value their online community and use it to access information, advice and support from 
peers who can truly identify with their predicament. It was apparent that people used the 
forum in different ways depending on their current life or health circumstances and, in line 
with similar research, it seems that online communities can help to meet social and 
emotional support needs for this population (Barber, 2008; van Uden-Kraan et al., 2008).   
 
In addition to the less formal provision of social and emotional support for people with CF, 
there may be a number of ways in which the online environment could be utilised for mental 
health and wellbeing services. The format of online discussion forums could be harnessed on 
a smaller, local scale and used to run psychoeducation, treatment adherence groups or 
psychotherapeutic groups without the risk of cross-infection. Video-conferencing facilities or 
web-cast links may be useful in promoting such contacts. An initial step towards making use 
of video-conferencing technology in CF care has been made at Nottingham City Hospital. 
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Fundraising efforts were successful in raising enough money to install video-conferencing 
facilities onto their CF ward to allow inpatients to communicate with each other and their 
families at home without the risks of cross-infection. It will be interesting to see whether this 
innovative introduction to inpatient care and its benefits to patients will be evaluated. 
7.7 DIRECTIONS FOR FUTURE RESEARCH 
This study of adults with CF who make use of online resources and social networking 
contributes to the current literature surrounding the mental health needs and wellbeing of 
adults with CF. It adds to this literature by explicitly considering self-esteem and its 
relationship with mental health symptoms and HRQoL. Furthermore, it provides an insight 
into the topics arising for discussion on a CF online forum. Inevitably, carrying out research 
and considering its findings within the context of published works leads to the development 
of further research questions. As outlined above, there are a number of possible clinical 
implications of this research, each with related avenues for research. In light of the 
discrepancies between estimates of mental health difficulties in the CF population, it may be 
worthwhile investigating the factors which influence resilience in the face of the challenges 
CF brings. This may include building on the work of Casier et al. (2008, 2011) and their 
focus on the role of acceptance in wellbeing of CF patients. Well-designed studies which 
take a longitudinal viewpoint of relevant factors may help disentangle the respective 
contributions of variables including gender, physical health status, social support, self-
esteem, acceptance and psychological wellbeing. In retrospect, two additions could have 
been made to the current online survey which may be addressed in further research.  Firstly, 
including a question asking participants to indicate whether or not they had received or were 
currently receiving input from psychology services would have been beneficial. This would 
have allowed calculation of the proportion of the mental health needs identified in this 
population which were unmet. Secondly, the use of a measure of perceived social support, 
such as the Significant Others Scale (Power et al., 1988) would have provided an insight into 
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the potential differences between social functioning as measured by the CFQ-R and social 
support. If distinctions are made between online and non-virtual relationships, exploring 
these would add to the understanding of how patients with CF perceive each type of support 
and the benefit, or disadvantages, provided. 
 
The beneficial impacts of online social support groups on the psychological well-being of 
people with CF are currently unknown. In other areas of health, a review paper suggests that 
there may be emotional benefits of involvement in online social support (Griffiths et al., 
2009). However the authors recognise that existing research in the area has considerable 
limitations and is generally of poor quality (Griffiths et al., 2009). Another paper 
acknowledged that there may also be the possibility of harm in being involved in online 
support networks (Takahashi et al., 2009). Further research may wish to focus on improving 
the quality of research in these areas but also in exploring the most beneficial and suitable 
types of support, particularly for those who already experience some level of mental health 
difficulty. It is known that a current randomised control study is underway in the USA 
looking at whether providing young people with CF with a web-enable phone, the 
CFFone
TM
, is beneficial for improving knowledge, treatment adherence and social support in 
youth with CF (Marciel et al., 2010). This provides access to a specific website with an 
online ‘chat’ environment which is overseen by psychology clinicians for incorrect medical 
information or potential psychological difficulties. It is hoped that the findings of this study 
will provide further knowledge on whether online support for people with CF is beneficial. 
 
For those patients with CF who do experience mental health problems, further research is 
required to ascertain the efficacy of psychological therapies and their most beneficial 
components. Research exploring the efficacy of common psychotherapeutic interventions is 
severely lacking in CF (Glasscoe & Quittner, 2008) and this needs to be addressed. 
Furthermore, segregation policies, physical health limitations and the distinct nature of CF 
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being a life-limiting and currently incurable disease may have impacts on the relevance for 
particular therapies. Traditional cognitive-behavioural therapy (CBT) approaches are now 
widely used across mental health services but often encourage patients to engage in 
increased activity and challenge unhelpful thought processes. However, patients with CF, 
especially those in the later stages of the disease, may be restricted by their physical 
functioning and the negative cognitions they experience may be related to realistic concerns 
about the future or current health situations. Therefore, it could be more relevant to explore 
options from other approaches such as acceptance and commitment therapy which has built 
an evidence-base for many problems stemming from both psychological and physical health 
problems (Kangas & McDonald, 2011; Pull, 2009). Finally, if group interventions are 
thought to provide advantages over and above individual psychotherapy, it is possible that 
new technologies such as video-conferencing may enable therapists to deliver interventions 
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Background: Despite research from the general population indicating an important role for 
self-esteem and social support in mental health, limited research into these two factors exists 
in the cystic fibrosis (CF) literature. Access to face-to-face CF peer support is limited due to 
segregation policies and internet technologies are becoming more frequently used to 
overcome this barrier. This study aimed to explore the relationships between self-esteem, 
mental health and health-related quality of life (HRQoL) in adults with CF who make use of 
online social support. 
Method: Seventy-four participants recruited via an online discussion forum completed 
assessments of mental health, self-esteem and HRQoL. 
Results: Comparably high levels of self-esteem were found, but HRQoL was lower than 
previous research. Thirty per cent of participants scored within the clinical range for mental 
health difficulty. Significant correlations indicated that lower self-esteem was associated 
with poorer quality of life and greater mental health difficulty. 
Conclusions: Results are discussed in relation to clinical implications and potential uses for 
internet technologies to promote socialisation.  
Key words: 
Cystic fibrosis; mental health; self-esteem; quality of life; online support; social functioning 
INTRODUCTION 
With the vast majority of people with cystic fibrosis (CF) now living into adulthood 
researchers have become increasingly interested in their long-term quality of life and 
psychological well-being. Studies have indicated that the CF population report high levels of 
quality of life (1) but that levels of mental health difficulty vary. Some studies suggest higher 
levels of depression and/or anxiety compared to the general population (2-4) whereas others 
maintain that levels of mental health symptoms are comparable to the general population (5). 
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The reasons for this variability continue to be explored by research and factors identified as 
influential include being female, older, unemployed and having more severe illness (2-4). 
 
Two factors which have been shown to play an important role in the mental health of the 
general population are self-esteem and social support. However, these two variables have 
received relatively little attention within the CF literature. Self-esteem has been linked with 
better mental health and psychological wellbeing in the general population (6) and has been 
shown to play an important role in mediating the relationship between dysfunctional 
thoughts and depression in adult participants (7). To the authors’ knowledge, only two 
papers have explicitly assessed self-esteem in adults with CF with both papers focusing 
primarily on body image (8, 9). A recent publication by Brucefors et al. (10) speculated that 
low levels of self-esteem may have contributed to the higher levels of social dysfunction 
found in their sample of adults with CF compared with healthy adults. However, there was 
no direct measurement of self-esteem within their project and, as yet, there appear to be no 
published studies which consider the relationship between self-esteem and mental health in 
adults with CF. 
 
Social support is important for adaptation to stress and higher levels of support are related to 
lower levels of mental health difficulty in the general population (11). Peer relationships 
have been seen to be affected in chronic illnesses (12) and, with the use of segregation in CF 
services to prevent cross-infection of respiratory bacteria, it is important to consider how 
people with CF can build and maintain relationships with and access support from their CF 
peers (13). The evidence from CF research overall seems to indicate that higher levels of 
social support and better levels of social functioning are related to better coping (14), 
improved adherence to treatment (14) and fewer mental health difficulties (15). Researchers 
have suggested that future studies continue to examine the potential buffering effects of 
social support (4) and explore how new technologies may enhance peer interaction and 
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overcome the restrictions of segregation for people with CF (13).  One option for keeping in 
contact with CF peers is to use the internet and social networking websites, where 
interactions can take place without the risks of cross-infection. Online resources are 
becoming increasingly popular (16) and may provide an additional means of peer support for 
people with CF. However, little research has been carried out in the area of online resources 
and the groups of CF patients who make use of specific resources available. As a starting 
point, the present study aimed to assess the mental health needs and HRQoL (including 
social functioning) of adults with CF who make use of online resources. In addition, it aimed 
to assess the levels of self-esteem within this group and explore the relationships of self-
esteem with mental health and HRQoL. In line with previous research involving the general 
population and CF patients, the authors hypothesised that lower self-esteem would be related 
to poorer mental health and lower levels of quality of life. Levels of mental health difficulty 
were hypothesised to be similar to recent research in CF which has indicated a slight 




This was a cross-sectional study of adults with cystic fibrosis who make use of online 
discussion forums and social networking. Participants completed three quantitative 
assessment measures and provided demographic information.  
PARTICIPANTS 
Participants were recruited through an online discussion forum and Facebook page hosted by 
the Cystic Fibrosis Trust (CF Trust), a UK-based charity. A total of 105 eligible participants 




Calculations were carried out to establish the size of correlation which could be confidently 
detected for a sample size of 74, an alpha level of .05 and 80 per cent statistical power. Using 
a two-tailed hypothesis, this revealed that analysis could detect correlations of r = .31, a 
medium effect size (17). 
 
Key demographic details for full and partially completed surveys were compared using non-
parametric chi-squared and Mann-Whitney U tests. No significant differences (p>.05) were 
found between full- and partial-completers on the demographic variables of age, FEV1% 
predicted, gender, ethnicity or lung transplant. Demographic variables for participants 
completing a full set of survey data are presented in Table 1. 
PROCEDURE 
Recruitment was initiated via a message posted on the CF Trust online discussion forum by a 
member of the CF Trust communications team. This linked to an information page 
describing the study. After 3 and 6 weeks, the researcher replied to the initial thread to thank 
those who had already taken part and to bring the notice to the top of the discussion area. In 
addition, 6 weeks after the original post on the CF Trust discussion forum, the 
communications team placed a recruitment notice on the CF Trust Facebook page followed 
by a repeat post from the researcher 2 weeks later. In total, the survey was open for ten 
weeks. 
 
The information page contained a web-link to the online survey, hosted by Survey Monkey 
(www.surveymonkey.com). Participants self-selected to take part in the research and were 
eligible if they were 16 years old or over and had a diagnosis of CF. Participants were asked 
to provide consent prior to completing the online survey. Those who chose not to consent 




Table 1. Demographic and basic clinical information summary for full data sets 
Demographic Clinical 
Age (mean ± SD) 27.8 ± 9.2   
Gender (n, % female) 57, 77.0% FEV1% (mean ± SD) 61.7 ± 25.0 
Ethnicity (n, % White) 72, 97.3% Lung transplant (n, % yes) 5, 6.8% 
Education (n, % Higher Ed) 45, 60.8%   
    
Marital Status (N = 74) n (%) Age at CF diagnosis (N = 74) n (%) 
 Single/never married 28 (37.8)  At birth 19 (25.7) 
 With a partner 25 (33.8)  <6 months old 18 (24.3) 
 Married/civil partnership 20 (27.0)  6 – 12 months old 10 (13.5) 
 Widowed 1 (1.4)  1 – 4 years old 13 (17.5) 
   5 – 11 years old 3 (4.1) 
Education (N = 74)   12 – 17 years old 3 (4.1) 
 Some secondary school or less 1 (1.3)  18 – 25 years old 3 (4.1) 
 GCSEs/O-levels 11 (14.9)  >25 years old 5 (6.7) 
 A/AS-levels 17 (22.9)   
 Other higher education 13 (17.6) CF Severity, No Transplant (FEV1%; N = 54) 
 University degree 21 (28.4)  Normal (FEV1% 90%) 6 (11.1) 
 Professional or postgraduate 11 (14.9)  Mild (70 – 89%) 13 (24.1) 
   Moderate (40 - 69%) 21 (38.9) 
Work Status (N = 61)   Severe (<40%) 14 (25.9) 
 Working full- or part-time 32 (52.5)    
 Not attending school or work due 
 to health 
12 (19.7) 
CF Severity, Transplant (FEV1%; N = 4) 
 Attending school 11 (18.0)  Normal (FEV1% 90%) 3 (75.0) 
 Seeking work 2 (3.3)  Moderate (40 - 69%) 1 (25.0) 
 Not working for other reasons 2 (3.3)   
 Taking education courses at home 1 (1.6)   




Cystic Fibrosis Questionnaire – Revised (CFQ-R) 
The CFQ-R (18, 19) is a CF-specific measure of health-related quality of life (HRQoL). The 
14 years and over teen/adult UK version was used in this instance. The measure consists of 
50 items which assess HRQoL within 9 domains. Previous research advocates the 
consideration of four core domains when studying HRQoL (15, 20) and, as a result, it was 
decided to include the CFQ-R subscales of physical functioning (eight items), emotional 
functioning (five items), role functioning (four items) and social functioning (six items). 
Each item on the CFQ-R is rated on a four-point Likert scale. A standardised score ranging 
between 0 – 100 is obtained for each subscale, with higher scores indicating better 
functioning. The CFQ-R teen/adult version is well established, valid and reliable (21). 
Cronbach’s alpha internal consistency analyses were carried out for each of the four 
subscales: physical α=.96, emotional α=.82, role α=.86 and social α=.63. 
Clinical Outcomes in Routine Evaluation – Outcome Measure 34 (CORE-OM) 
The CORE-OM (22) is a 34-item self-report measure used to assess psychological and 
emotional distress. A total score can be calculated in addition to scores for four sub-domains: 
subjective well-being, functioning, symptoms and risk. Each item is rated on a four-point 
scale from 0 (not at all) to 4 (most or all of the time). Higher scores indicate greater 
difficulty. The measure has been shown to be reliable, valid and able to distinguish between 
clinical and non-clinical samples in the general population (23). CORE-OM total scores in 
the current sample had good internal consistency, Cronbach’s α=.96. 
Rosenberg self-esteem scale (24) 
This 10-item self-report questionnaire is designed to measure global self-esteem. Each item 
is rated on a four-point scale (strongly disagree, disagree, agree, strongly agree) and results 
in a total score ranging from 10 – 40. Higher scores represent higher levels of self-esteem. 
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This measure has been shown to have satisfactory psychometric properties (25) and has been 
used in CF research (9). The current data had good internal consistency, Cronbach’s α=.94. 
Demographic questionnaire 
Demographic data including age, gender, occupation, diagnosis and current physical health 
status (including most recent FEV1% predicted reading and lung transplant status) were 
collected. FEV1% predicted is a measure of lung function frequently used to classify severity 
of respiratory disease.  
DATA ANALYSIS 
Raw data were analysed using SPSS version 17. Scores for those participants who had fully 
completed the online survey (N = 74) were included in analyses. Kolmogorov-Smirnov 
statistical tests determined the normality of data distribution for FEV1% predicted and each 
outcome measure variable. Data was normally distributed for all variables (p>.05) except for 




Past research has suggested gender differences in HRQoL and psychological well-being in 
CF (26). Due to the unequal proportions of males and females in the current study, t-test 
comparisons of male and female mean scores on each outcome measure and FEV1% 
predicted were carried out.  
Correlations 
Pearson’s correlations were conducted between FEV1% predicted and the three standardised 
outcome measures. Consideration was given to removing data of participants who had 
                                                 
2
 The researcher explored the benefit of transforming data using a square-root function. This 
succeeded in distributing scores normally (D = 0.14, p = .11). However, as the transformed scores did 
not result in any differences in the significance of subsequent statistical analyses compared to when 
using raw scores, it was decided to use the raw data for ease of interpretation of findings. 
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undergone a lung transplant. Given the small number of participants who were post-
transplant (N = 5) and, as mean scores were not changed significantly when excluded, it was 
decided to include their data in subsequent analyses.  
ETHICAL APPROVAL  
Ethical approval was obtained from the School of Health in Social Science, University of 
Edinburgh research ethics panel. Collaboration with the CF Trust aided the development of 
the project and research information page. 
RESULTS 
DESCRIPTIVE STATISTICS 
Table 2 presents the mean and standard deviation (SD) for each measure completed within 
the online survey. Self-esteem scores produced a mean of 29.9 (SD 7.1). The mean score on  
 
Table 2. Means and standard deviations of outcome measure scores 
Mean scores (SD) 
Outcome measures 
Male Female Total 
FEV1% predicted 66.73 (26.9) 60.47 (24.6) 61.66 (25.0) 
Physical functioning 58.82 (37.6) 43.42 (30.3) 46.96 (32.5) 
Role functioning 71.57 (23.8) 63.73 (23.2) 65.61 (23.4) 
Emotional functioning** 71.76 (20.9) 52.98 (24.2) 57.30 (24.6) 
CFQ-R 
Social functioning** 70.59 (15.6) 55.85 (20.5) 59.23 (20.4) 
CORE-OM total score* 0.64 (0.5) 1.13 (0.7) 1.01 (0.7) 
Rosenberg self-esteem scale** 33.94 (5.1) 28.68 (7.2) 29.89 (7.1) 
* gender difference significant at the level of p<.05 
** gender difference significant at the level of p<.01 
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the CORE-OM was 1.01 (SD 0.7) and when classified according to clinical thresholds, 29.7 
per cent (N = 22) of participants were within clinical range of symptoms. Average scores on 
the CFQ-R subscales ranged between 46.96 (SD 32.5) for physical functioning and 65.61 
(SD 23.4) for role functioning. Mean scores of 57.30 (SD 24.6) and 59.23 (SD 20.4) were 
obtained for emotional and social functioning respectively.  
CORRELATIONS 
The results of the Pearson’s correlation analyses are presented in Table 3. Significant 
positive correlations were found between the four subscales of the CFQ-R. Correlations 
between CFQ-R subscales and CORE-OM total score were all negative, with lower HRQoL 
scores associated with higher levels of mental health difficulty. Significant positive 
correlations between CFQ-R subscales and self-esteem scores were also found, indicating 
that better HRQoL is related to higher levels of self-esteem. Higher self-esteem scores were 
also associated with lower levels of mental health difficulty. Disease severity correlated 
positively with CFQ-R subscales of physical, role and social functioning. This suggests that 
those with better lung function experience better quality of life in these domains. The only 
non-significant correlations were found between disease severity and emotional functioning, 
CORE-OM total score and self-esteem. 
GENDER DIFFERENCES 
Exploratory two-tailed t-tests were carried out to compare scores of males (N = 17) and 
females (N = 57) on each measure. Mean scores, standard deviations and significance can be 
found in Table 2. Females scored significantly lower than males on the CFQ-R domains of 
emotional functioning (t = 2.897, p = .005) and social functioning (t = 2.730; p = .008). They 
were also seen to have lower levels of self-esteem (t = 2.813; p = .006) and higher total 










































































































































































































































































































































































































































































































predicted (t = 0.746; n.s.), physical functioning (t = 1.739; n.s.) or role functioning (t = 1.208; 
n.s.) were found. 
DISCUSSION 
Results showed that participants had good levels of self-esteem which compared well to 
previous CF participants and healthy controls (9). Mental health symptoms were at clinical 
levels for 29.7 per cent of the sample, which is higher than would be expected within the general 
population (27). However, this finding is in line with other studies indicating elevated mental 
health difficulties in the CF population (2-4). The results indicate that participants had variable 
levels of HRQoL depending on domain. Lowest scores were obtained in physical functioning 
whilst highest score were seen in role functioning. Role functioning refers to how much CF 
interferes with attending and keeping up with school, work or daily living activities. It also 
assesses whether CF interferes with achieving goals in areas of school, work or personal life. 
Compared to the baseline assessment scores reported in a recent longitudinal study of HRQoL in 
adults with CF (28), domain scores within this study are considerably lower. Sawicki et al.’s 
(28) sample were of a similar mean age (26.9 years, SD 9.7) and severity (FEV1% 61.0, SD 
23.0) yet mean scores for the four CFQ-R domains were: physical 67.9 (SD 27.4), role 81.1 (SD 
19.4), emotional 76.3 (SD 20.0) and social 71.6 (SD 17.9).  
 
One potential reason for the lower overall mean levels of quality of life compared to other 
studies may be due to the over-representation of females within the current sample population. 
Prior research has established that females with CF tend to fair worse medically than males (29) 
and that there are gender differences in psychological wellbeing. Females have been shown to 
experience higher levels of anxiety (3, 4), lower self-esteem (9) and lower HRQoL (1). The 
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current study presents data supporting the fact that females with CF tend to face greater 
difficulties with self-esteem, mental health symptoms and HRQoL compared to males.  
 
Correlation analyses between outcome variables revealed that higher self-esteem was related to 
better mental health and better HRQoL. The significant relationships between higher mental 
health difficulty and lower levels of quality of life in all domains, including social functioning, 
are consistent with the results of previous research (2, 15). In terms of self-esteem, there are few 
studies which have considered the role of this construct in relation to mental health and HRQoL 
in the CF population. The significant relationships found within this study mirror the association 
between mental health and self-esteem in the general population (6). In addition, as suggested by 
Brucefors et al. (10), it suggests that self-esteem may have a role to play in low levels of social 
functioning and psychological wellbeing of adults with CF. 
 
Significant correlations were also found between severity of CF disease (as measured by FEV1% 
predicted) and physical, role and social functioning quality of life domains. However, no 
significant relationship was found between FEV1% predicted and emotional functioning, mental 
health difficulty or self-esteem. FEV1% predicted is a clinical measure used to gauge level of 
lung functioning and, therefore, lower scores indicate more severe lung disease. It follows that 
those people with poorer lung functioning will have more limitations on their physical health, be 
less able to carry out some roles within families, relationships or employment and be less able to 
socialise with friends. 
Limitations 
As with all research studies a number of limitations can be highlighted. Firstly, it is recognised 
that participants were self-selected and the sample is therefore unlikely to be fully representative 
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of the target population. Secondly, participants were asked to self-report their most recent 
FEV1% predicted score and the accuracy of this can not be guaranteed. However, it was seen 
that the average lung function fell in the region of previous studies of CF patients recruited from 
clinical settings (28). Thirdly, one of the difficulties with the use of correlation statistics is that 
causality cannot be inferred. Although there are clearly relationships between variables, the 
influential impacts between them cannot be defined. Fourthly, the CORE-OM 34 was selected 
for its consideration of a wide range of symptoms rather than a focus on only one subset of 
symptoms, e.g. depression or anxiety. However, existing studies within CF make use of differing 
measures, making direct comparisons more difficult. Despite this, data was presented as the 
proportion of participants who scored above recommended clinical thresholds which allowed 
comparison with other studies. 
Clinical implications and future research 
This study of adults with CF who make use of online resources and social networking 
contributes to the current literature surrounding the mental health needs and wellbeing of adults 
with CF. Its novel contribution is in the exploration of self-esteem and its relationship with 
mental health symptoms and HRQoL. The current study reveals that higher levels of self-esteem 
are associated with better mental health and quality of life in adults with CF. Future studies 
which take a longitudinal approach in assessing relevant factors in psychological wellbeing and 
mental health may help disentangle the respective contributions such variables as gender, 
physical health status, social support and self-esteem. Factors which influence resilience in the 
face of the challenges CF brings might also be worthy of research. This work may build on a 




Despite the ongoing inconsistencies in reports of the prevalence of mental health problems in 
adults with CF, the impacts of difficulties where they do occur can have wide-ranging 
implications for HRQoL and treatment adherence (2). Given the gender differences in levels of 
mental health difficulty and self-esteem in the present study, it may be useful for clinical 
psychologists working within CF services to remain particularly vigilant for difficulties in 
females. In addition, in light of the relationship between poorer self-esteem and greater mental 
health difficulty for both males and females, the wider health team could be supported by 
clinical psychologists to recognise signs of low self-esteem and early detection of mental health 
difficulty. Where clinical levels of distress are identified, psychological therapies may be a 
useful treatment intervention. Traditional cognitive behavioural approaches may prove 
efficacious in this task but direct focus on self-esteem may also be beneficial. Further empirical 
research assessing the efficacy of psychological therapies in CF is still required (30). The value 
of emotional, psychological and peer support for people with long-term physical health 
conditions has been recently recognised by Scottish Government (31). Key international 
researchers also recognise that in order to enhance opportunities for people with CF to develop 
peer-support networks, use of technology needs to be explored (13). Online discussion forums 
and support groups present an environment for people with CF to access peer support and these 
resources are becoming more widely recognised as a viable option (16). The current sample of 
participants with CF who used online resources experienced lower levels of HRQoL than 
reported in previous literature and greater mental health difficulty compared to the general 
population. This may indicate that online forums are used by those who are more impaired or 
isolated due to their CF compared to the average patient with CF who is recruited into research 
studies via clinic situations. Further good quality research is required in order to provide insight 
into whether this medium of support can be beneficial. A review of the literature examining the 
effects on depression of involvement with internet support groups showed promise in some 
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areas, particularly for people suffering with breast cancer, but highlighted the shortage of well-
designed studies (32). In relation to CF, a current randomised control trial in the USA is 
examining the influence of CF-specific online support on perceived social support, adherence 
and CF knowledge (33). This will be a useful addition to the literature and may be followed by 
further research to clarify the efficacy of online support for people with CF. 
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APPENDIX A: SYSTEMATIC REVIEW PROFORMAS  
 
Critical Review and Data Extraction Proforma 






Type of publication:  
Country of origin:  
Source of funding:  
 
Section 1: Internal validity 
In a well conducted study... In this study the criterion is: 








Not applicable  
 
SELECTION OF PARTICIPANTS  
1.2 The group(s) being studied is/are selected from appropriate 
source populations (and are comparable in all respects other 







Not applicable  
 
1.3 The study indicates how many of the people asked to take 









1.4 What percentage of individuals or clusters recruited 
dropped out before the study was completed. 
 
 
1.5 Comparison is made between full participants and those 



















1.7 Evidence from other sources is used to demonstrate that the 









CONFOUNDING VARIABLES  
1.8 The main potential confounders are identified and taken 









STATISTICAL ANALYSIS  
1.9 Appropriate statistics were used. Yes / No 
 
Type of analysis: 
 
 


















1.12 Authors report appropriate statistical figures e.g. p-values, 








Section 2: OVERALL ASSESSMENT OF STUDY 
2.1 How well was the study done to minimise the risk of bias or 
confounding, and to establish a causal relationship between 
exposure and effect? 
 
Add up scores for each item in section 1 
 
 
Total Score –  
Total possible score = 20 if all items 
applicable. 
 
(well covered = 2, adequately 
covered = 1, poorly addressed, not 
addressed, not reported = 0) 
2.2 Taking into account clinical considerations, your evaluation 
of the methodology used, and the statistical power of the study, 
are you certain that the overall effect is due to the factors being 
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investigated? 
SECTION 3: DATA EXTRACTION 
3.1 How many patients are included in this study? 
 
 










3.3 How many centres are participants recruited from? 
 
 
3.4 What were the inclusion criteria? 
 
 
3.5 What were the exclusion criteria? 
 
 
3.6 What outcome measure(s) are used in the study? 
List all outcomes that are used to assess the factors being 
examined in the study 
 
 
3.7 Were data from participants who dropped out compared to 




Number of participants who did not 
complete: 
 
3.8 What were the outcomes of the measures used?  
Measure n Mean Std Dev. 
1.    
2.    
3.    
4.    
5.    
6.     
3.9 What comparisons are made in the study? 
 
Are comparisons made between presence or absence of an 








3.11 Does this study help to answer your key question? 
Summarise the main conclusions of the study and indicate how 
it relates to the key question? 
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Critical Review and Data Extraction Proforma – QUALITATIVE STUDIES 








Type of publication:  
Country of origin:  
Source of funding:  
1: Internal validity 
1. Was there a clear statement of the aims of the research? 
What the goal was 




2. Is a qualitative methodology appropriate? 
If the research seeks to interpret or illuminate the actions 
and/or subjective experiences of research participants. 
 
 
Is it worth continuing?  
3. Was the research design appropriate to address the aims 
of the research? 
If the researcher has justified the research design (e.g. 




4. Was the recruitment strategy approrpaite to the aims of 
the research? 
If the researcher has explained how the participants 
were selected. 
If they explained why the participants they selected were 
the most appropriate to provide access to the type of 
knowledge sought by the study 
If there are any discussion around recruitment (e.g. why 
some people chose not to take part) 
 
 
5. Were the data collected in a way that addressed the 
research issue? 
If the setting for data collection was justified 
If it is clear how data were collected (e.g. focus group, 
semi-structured interview) 
If the researcher has justified the methods chosen 
If the researcher has made the methods explicit 
If methods were modified during the study. How and 
why? 
If the form of data is clear 
If the researcher has discussed saturation of data. 
 
 
6. Has the relationship between researcher and participants 
been adequately considered? 
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If the research critically examined their own role, 
potential bias, and influence during formulation of 
research questions and data collection 
How research responded to events during the study and 
whether they considered the implications of any change 
in the research design 
 
7. Have ethical issues been taken into consideration? 
If there are sufficient details of how the research was 
explained to participants for the reader to assess 
whether ethical standards were maintained 
If the research has discussed issues raised by the study 
If approval has been sought from the ethics committee 
 
 
8. Was the data analysis sufficiently rigorous? 
If there is an in-depth description of the analysis process 
If thematic analysis is used, clear how the themes/cats 
were derived? 
Whether the researcher explains how the data presented 
were selected from the original sample to demonstrate 
the analysis process 
If sufficient data are presented to support the findings 
To what extent contradictory data are taken into account 
Whether the research critically examined their own role, 
potential bias and influence during analysis and selection 
of data for presentation 
 
 
9. Is there a clear statement of findings? 
If the findings are explicit 
If there is adequate discussion of the evidence both for 
and against the researchers arguments 
If the researcher has discussed the credibility of their 
findings 




10. How valuable is the research? 
If the research discusses the contribution the study 
makes to existing knowledge or understanding 
If they identify new areas where research is necessary 
If the researchers have discussed whether or how the 
findings can be transferred to other populations or 





SECTION 3: DATA EXTRACTION 
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3.4 What were the inclusion criteria? 
 
 
3.5 What were the exclusion criteria? 
 
 
3.6 What outcome measure(s) are used in the 
study? 
List all outcomes that are used to assess 
the factors being examined in the study 
 
 




3.8 What comparisons are made in the study? 
Are comparisons made between presence 
or absence of an environmental / 








3.10 Does this study help to answer your key 
question? 
Summarise the main conclusions of the 
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School of Health in Social Science 
                                                                                                                    Medical School, Teviot Place 
                                                                                                                Edinburgh   
         EH8 9AG 
 
Telephone: 0131 651 3972  













Re: Project Title: Cystic Fibrosis, psychological well-being and online social support 
 
 
Your proposal has been reviewed and approved by the Programme Ethics Panel. The 
following comments are for your guidance only and should be discussed with your 
supervisor.  
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Ethics Approval Letter…. Cont’d 
 
 
Researcher: Melanie Platten, Trainee Clinical Psychologist 
Project Title: Cystic Fibrosis, psychological well-being and online social support 
 
 
• The revised proposal is improved and Melanie has worked hard to address the 
comments.  All of the points I raised have been dealt with satisfactorily.  I am, 
however, unsure of the decision to extend the age range of the participants - I 
suspect that it is unlikely that the issues that preoccupy a 16 year old will have 
much in common with those of a 30 year old.  I would encourage Melanie to 
either, (i) stick with an adolescent population or, if necessary, (ii) increase the 
upper age limit to perhaps 21, to fall within the category of 'young adult'.  On 
that note, the information leaflet talks about 'young people' and I wouldn't class a 
30 year old within that bracket.  
• The revised project seems to involve analyses using the measures that are not 
outlined in the research questions section. It would benefit from being clearer 
about the research question(s) that the project seeks to address.  
• The researcher(s) should consider the issue of the internet forum being used by 
CF patients who do not actually post to the forum. These individuals may benefit 
from the forum, despite only reading rather than contributing. Arguably 
individuals with depression or low self-esteem might be more likely to engage in 
such passive forum use. This is probably just something to consider in the thesis 
discussion.  
• The project may wish to take step(s) to ensure that the person who gives consent 
is actually the person connected with a given username (e.g. by asking them to 
post something) prior to using that username's data. 
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Hi Melanie,  
 
That sounds fine to me, and as before, we would probably make the initial post from us, to show 
that it is all legit. 
 





From: Platten Melanie (NHS DUMFRIES & GALLOWAY) 
Sent: 30 November 2010 09:57 
To: John Devlin 
Subject: Research 
Hi there John, 
I emailed a few weeks ago about changes to my thesis planned project. As I mentioned, the 
research team felt that my original idea of doing a straight qualitative analysis of the 
forum posts wasn't strongly enough linked to clinical aspects of my course. After some 
consideration of alternative ideas which did not use online info, we have had a rethink about the 
project. I was hoping that it may be possible to still use the CF Trust Forum? 
  
In order to increase the links to clinical practice and to overcome some of the concerns regarding 
users giving their informed consent for posts to be used in research, we have come up with the 
idea of asking users to fill in a questionnaire online (via survey monkey) within which would be 
an information page, consent form and a couple of brief questionnaires. I should have a full 
research protocol written up in the next week or two which I can send you for more info. I just 
wanted to check with you to make sure that using the forum would still be a possibility? The 
vague time line would be to go back to the uni ethics committee in December, finalise project 
details in January and hopefully collect data from February - April 2011. 
  
Sorry that things have changed around a bit! I hope that you can help and look forward to 




Clinical Psychologist in Training 
PPALS, Royal Hospital for Sick Children, 3 Rillbank Terrace, Edinburgh
John Devlin 
Sent: 01 December 2010 10:55  
To: Platten Melanie (NHS DUMFRIES & GALLOWAY) 




Sent: 07 February 2011 10:45  
To: Platten Melanie (NHS DUMFRIES & GALLOWAY) 
 
Hi Mel,  
  
The page is now up and I will put the post on the forum today.   
The page is here: http://www.cftrust.org.uk/aboutcf/livingwithcf/supres 





From: Platten Melanie (NHS DUMFRIES & GALLOWAY) 
Sent: 03 February 2011 12:42 
To: John Devlin 
Subject: Approval letter and updated information page 
Hi there John, 
  
I've finally received an official letter from my ethics tutor - please see attached. 
 I've also attached an updated version of the protocol and information page. We decided to take 
off the upper age limit for the study to hopefully encourage as many people to take part as 
possible, so it's now for people aged 16 and up. The information page attached (dated 3rd Feb) is 
the most recent one and superseeds others. Sorry to keep changing things but I promise this is 
the final version! 
  
Also, I've added in the website of the survey onto the information page so that people can get 
started and fill in the survey. For your info, the web address for the survey is: 
https://www.surveymonkey.com/s/CF_onlinesocialsupport 
  
When do you think it would be possible to get the information page up on the site and the initial 
posting? For me, it would be ideal if it could be up by the beginning of next week if at all 
possible. 
  






Clinical Psychologist in Training 
PPALS, Royal Hospital for Sick Children, 
3 Rillbank Terrace, Edinburgh. 
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Article structure  
Manuscripts should be prepared according to the guidelines set forth in the Publication Manual of the American 
Psychological Association (6th ed., 2009). 
 
Manuscripts should ordinarily not exceed 50 pages. Exceptions may be made with prior approval of the Editor in 
Chief for manuscripts including extensive tabular or graphic material, or appendices. 
 
Appendices  
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices 
should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. 
Similarly for tables and figures: Table A.1; Fig. A.1, etc. 
 
Essential title page information  
 
Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and 
formulae where possible. Note: The title page should be the first page of the manuscript document indicating the 
author's names and affiliations and the corresponding author's complete contact information.  
 
Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this 
clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all 
affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate 
address. Provide the full postal address of each affiliation, including the country name, and, if available, the e-mail 
address of each author within the cover letter. 
 
Corresponding author. Clearly indicate who is willing to handle correspondence at all stages of refereeing and 
publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are 
provided in addition to the e-mail address and the complete postal address.  
 
Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at 
the time, a "Present address"' (or "Permanent address") may be indicated as a footnote to that author's name. The 
address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic 
numerals are used for such footnotes. 
 
Abstract  
A concise and factual abstract is required (not exceeding 200 words). This should be typed on a separate page 
following the title page. The abstract should state briefly the purpose of the research, the principal results and major 
conclusions. An abstract is often presented separate from the article, so it must be able to stand alone. References 
should therefore be avoided, but if essential, they must be cited in full, without reference to the reference list. 
 
Highlights  
Highlights are mandatory for this journal. They consist of a short collection of bullet points that convey the core 
findings of the article and should be submitted in a separate file in the online submission system. Please use 
'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters including spaces, or, maximum 
20 words per bullet point). See http://www.elsevier.com/highlights for examples. 
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Keywords  
Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and 
plural terms and multiple concepts (avoid, for example, "and", "of"). Be sparing with abbreviations: only 
abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes. 
 
Abbreviations  
Define abbreviations that are not standard in this field in a footnote to be placed on the first page of the article. Such 
abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well as in the 
footnote. Ensure consistency of abbreviations throughout the article. 
 
Acknowledgements  
Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, 
include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help 
during the research (e.g., providing language help, writing assistance or proof reading the article, etc.). 
 
Footnotes  
Footnotes should be used sparingly. Number them consecutively throughout the article, using superscript Arabic 
numbers. Many wordprocessors build footnotes into the text, and this feature may be used. Should this not be the case, 
indicate the position of footnotes in the text and present the footnotes themselves separately at the end of the article. 
Do not include footnotes in the Reference list.  
Table footnotes  
Indicate each footnote in a table with a superscript lowercase letter. 
 
Electronic artwork  
General points  
• Make sure you use uniform lettering and sizing of your original artwork.  
• Save text in illustrations as "graphics" or enclose the font.  
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.  
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Provide captions to illustrations separately.  
• Produce images near to the desired size of the printed version.  
• Submit each figure as a separate file.  
 
A detailed guide on electronic artwork is available on our website:  
http://www.elsevier.com/artworkinstructions  
 
Color artwork  
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct 
resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no 
additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of 
whether or not these illustrations are reproduced in color in the printed version. For color reproduction in print, you 
will receive information regarding the costs from Elsevier after receipt of your accepted article. Please indicate 
your preference for color in print or on the Web only. For further information on the preparation of electronic artwork, 
please see http://www.elsevier.com/artworkinstructions.  
Please note: Because of technical complications which can arise by converting color figures to "gray scale" (for the 
printed version should you not opt for color in print) please submit in addition usable black and white versions of all 
the color illustrations. 
 
Figure captions  
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should 
comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations 
themselves to a minimum but explain all symbols and abbreviations used. 
 
Tables  
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table 
body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and 
ensure that the data presented in tables do not duplicate results described elsewhere in the article. 
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References  
Citations in the text should follow the referencing style used by the American Psychological Association. You are 
referred to the Publication Manual of the American Psychological Association, Sixth Edition, ISBN 1-4338-0559-6, 
copies of which may be ordered from http://books.apa.org/books.cfm?id=4200067 or APA Order Dept., P.O.B. 2710, 
Hyattsville, MD 20784, USA or APA, 3 Henrietta Street, London, WC3E 8LU, UK. Details concerning this 
referencing style can also be found at http://humanities.byu.edu/linguistics/Henrichsen/APA/APA01.html 
 
Citation in text  
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references 
cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in 
the reference list, but may be mentioned in the text. If these references are included in the reference list they should 
follow the standard reference style of the journal and should include a substitution of the publication date with either 
"Unpublished results" or "Personal communication" Citation of a reference as "in press" implies that the item has been 
accepted for publication. 
 
Web references  
As a minimum, the full URL should be given and the date when the reference was last accessed. Any further 
information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web 
references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included 
in the reference list. 
 
References in a special issue  
Please ensure that the words 'this issue' are added to any references in the list (and any citations in the text) to other 
articles in the same Special Issue. 
 
Reference management software  
This journal has standard templates available in key reference management packages EndNote (  
http://www.endnote.com/support/enstyles.asp) and Reference Manager (  http://refman.com/support/rmstyles.asp). 
Using plug-ins to wordprocessing packages, authors only need to select the appropriate journal template when 
preparing their article and the list of references and citations to these will be formatted according to the journal style 
which is described below. 
 
Reference style  
 
References should be arranged first alphabetically and then further sorted chronologically if necessary. More than one 
reference from the same author(s) in the same year must be identified by the letters "a", "b", "c", etc., placed after the 
year of publication. References should be formatted with a hanging indent (i.e., the first line of each reference is 
flush left while the subsequent lines are indented).  
 
Examples: Reference to a journal publication: Van der Geer, J., Hanraads, J. A. J., & Lupton R. A. (2000). The art of 
writing a scientific article. Journal of Scientific Communications, 163, 51-59.  
 
Reference to a book: Strunk, W., Jr., &White, E. B. (1979). The elements of style. (3rd ed.). New York: Macmillan, 
(Chapter 4).  
 
Reference to a chapter in an edited book: Mettam, G. R., & Adams, L. B. (1994). How to prepare an electronic version 
of your article. In B.S. Jones, & R. Z. Smith (Eds.), Introduction to the electronic age (pp. 281-304). New York: E-
Publishing Inc. 
 
Supplementary data  
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary 
files offer the author additional possibilities to publish supporting applications, high-resolution images, background 
datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version 
of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure 
that your submitted material is directly usable, please provide the data in one of our recommended file formats. 
Authors should submit the material in electronic format together with the article and supply a concise and descriptive 
caption for each file. For more detailed instructions please visit our artwork instruction pages at 
http://www.elsevier.com/artworkinstructions. 
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Submission checklist  
The following list will be useful during the final checking of an article prior to sending it to the journal for review. 
Please consult this Guide for Authors for further details of any item.  
Ensure that the following items are present:  
One Author designated as corresponding Author:  
• E-mail address  
• Full postal address  
• Telephone and fax numbers  
All necessary files have been uploaded  
• Keywords  
• All figure captions  
• All tables (including title, description, footnotes)  
Further considerations  
• Manuscript has been "spellchecked" and "grammar-checked"  
• References are in the correct format for this journal  
• All references mentioned in the Reference list are cited in the text, and vice versa  
• Permission has been obtained for use of copyrighted material from other sources (including the Web)  
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or 
to be reproduced in color on the Web (free of charge) and in black-and-white in print  
• If only color on the Web is required, black and white versions of the figures are also supplied for printing purposes  
For any further information please visit our customer support site at http://support.elsevier.com. 
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APPENDIX E: COPY OF ONLINE SURVEY FOR STUDY 1 
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I don’t believe that there is an issue with the transferring of the CFQ-R. 
  
This should be with you early next week. 
  








Forest Laboratories UK Ltd 
Riverbridge House 
Anchor Boulevard 





From: Platten Melanie (NHS DUMFRIES & GALLOWAY)  
Sent: 09 December 2010 17:57 
To: Matt Brown 
Subject: RE: CFQ-R permissions 
  
Hi there Matthew, 
  
Thanks for getting back to me and for sending through the information. My address is at the bottom of 
this email if you could send things there. 
  
Can I take it that there is no copyright problem with transferring the CFQ-R onto my surveymonkey 






Clinical Psychologist in Training 
  
PPALS, Royal Hospital for Sick Children, 





Sent: 10 December 2010 09:29  
To: Platten Melanie (NHS DUMFRIES & GALLOWAY) 
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From: Matt Brown 
Sent: 09 December 2010 11:00 
To: Platten Melanie (NHS DUMFRIES & GALLOWAY) 
Subject: CFQ-R permissions 
  
Good Morning,  
  
Following on from our discussion, I shall be sending a CFQ pack to you. In addition, there are some 
attachments to this email which help with the CFQ. 
  
First is the CFQ presentation given by Mandy Bryon from GOSH in April 2009. This helps explain 
the CFQ & in addition the overview PDF. 
  
The pack uses the CFQ (USA version) of the disc. This has a glitch in it, which isn’t anything we can 
reverse, (as it wasn’t a Forest disc to start with). 
  
The word document should help explain this. 
  








Forest Laboratories UK Ltd 
Riverbridge House 
Anchor Boulevard 
Crossways Business Park 
Dartford, Kent 
DA2 6SL 
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Rebecca Hoskin 
Sent: 20 December 2010 09:48  
To: Platten Melanie (NHS DUMFRIES & GALLOWAY) 




Please see response from our Managing Director below, 
  
  
Could you please permission this request on my behalf and explain that Richard Evans is off 
ill. 
  











Rebecca Hoskin – Customer Support   
tel: 01788 546019 
fax: 01788 331407 
  
Please note the CORE administration office will be closed from 24th December and re-open 
Tuesday 04th January 2011.  
  
All the team at CORE IMS wish you a very happy holiday season and all the best for 2011 
  
  
 -----Original Message----- 
From: Platten Melanie (NHS DUMFRIES & GALLOWAY)  
Sent: 14 December 2010 11:27 
To: Admin 




I recently tried get in touch with you (via riche@btclick.com) to ask permission to use the 
CORE-34 items electronically for my Doctoral research project. My thesis project will be 
carried out online and participants recruited via a website and then completing a survey 
online. I wondered whether it would be possible to gain permission to transfer the items of 
the CORE onto my online survey for use within this context? I would, of course, reference 
the questionnaire appropriately and maintain the order, wording and ratings of each items as 
on the forms. The survey will make use of survey monkey for ease of creation and collection 
of data. It is hoped that data collection using the survey will be open for participants between 
February to April 2011. I am about submit my project to an ethics committee and would very 
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much like to use the CORE if at all possible. I do not have a budget for my project so hope 
that there would be no large fee for doing this if permission was granted. 
  





Clinical Psychologist in Training 
  
PPALS, Royal Hospital for Sick Children, 
3 Rillbank Terrace, Edinburgh. 
  
________________________________________ 
From: admin@coreims.co.uk  
Sent: 07 December 2010 15:41 
To: Platten Melanie (NHS DUMFRIES & GALLOWAY) 
Subject: CORE System Forms 
  
Thank you for your enquiry to CORE Information Management Systems (CORE IMS) 
requesting CORE System forms. The forms you requested are attached. 
  
Please note that these are for your own use in connection with your therapy practice, service 
or research, as outlined in the Conditions of Use statement. Please do not resend this email or 
the forms electronically. If you know others who may wish to access the forms please direct 
them to the Resources section of our website www.coreims.co.uk. 
  
CORE IMS is the sole organisation licensed by the CORE System Trust to provide support 
for CORE System users. This includes training in implementing the CORE System and using 
CORE System data in practitioner and service development. CORE IMS also provides 
CORE PC software to support the development of excellence in practice and service delivery 
– visit our website www.coreims.co.uk for further details 
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 May 2011 
Forum Post - Qualitative Indexing Framework 
 
1. CF treatment 
1.1. Nebulisers, antibiotics and doseage 
1.2. Length of time to take treatments 
1.3. Fitting in treatment into everyday life 
1.4. Pro’s and con’s of different treatment 
methods 
1.5. Highlighting the important of 
treatments 
1.6. Side-effects 
1.7. Lung transplant 
1.8. New developments in treatments 
1.9. Inpatient stays 
1.10. CF Unit facilities 




2. Medical procedures 
2.1. Blood tests 
2.2. IV antibiotics 
2.3. Ports 
2.4. Pain 
2.5. Fear or panic 
2.6. Ways of coping and tips for comfort 
2.7. Inexperience medical staff 
2.8. Other 
 
3. Health topics 
3.1. Improvements in health 
3.2. Health advice seeking 
3.3. Information about aspects of non-CF 
health e.g. migraines, dental 
3.4. Respiratory Infections 
3.5. Effects of pregnancy 
3.6. Menstruation 
3.7. Speaking to health team 
3.8. Other 
 
4. Daily living issues and occupation 
4.1. Education inc. school and university 
attendance or exams 
4.2. Work and employment 
4.3. Interviews – disclosing diagnosis 
4.4. Practical tips about comfortable 
clothing 
4.5. Mobility / cars 
4.6. DLA and benefits 
4.7. Smokers in public 
4.8. Fitness and running 
4.9. Non-CF issues e.g. heating at home 
4.10. Past-times and hobbies 
4.11. Other 
 
5. Psychosocial and inter-personal 
relationships 
5.1. Self-esteem 
5.2. Adjusting to changes in health / 
treatment 
5.3. Self-help services and groups 
5.4. Friends not understanding 
5.5. Feeling different or “special” 





6.1. Fear of what the future holds 
6.2. Hope 
6.3. Pregnancy, fertility and genetics 
6.4. Parenting with CF 
6.5. Morality of having children 
6.6. Other 
 




7.4. Sharing experiences 
7.5. Giving information or advice 
7.6. Providing opinion or alternative 
viewpoint 
7.7. Seeking support 
7.8. Giving condolences after a death 
7.9. Well-wishing 
7.10. Thanks 
7.11. Use of humour 
7.12. Clarifying tone / intention 
7.13. Diffuse potential arguments 
7.14. Other 
 
8. Other key issues (not covered above) 
8.1. CF related 
8.2. Non-CF related 
  
 
Appendix H – Qualitative index frameworks 
166  




 May 2011 
Forum Post - Qualitative Indexing Framework 
 
1. CF treatment 
1.1. Nebulisers, antibiotics and 
doseage 
1.2. Physiotherapy 
1.3. Exercise tests 
1.4. Lung transplant 
1.5. Fitting in treatment into 
everyday life 
1.6. Pro’s and con’s of different 
treatment methods 
1.7. Side-effects 
1.8. Highlighting the important of 
treatments 
1.9. CF Unit facilities 
1.10. Segregation 
 
2. Medical procedures 
2.1. Blood tests 




2.6. Health staff skills 
 
3. Health topics 
3.1. Improvements or exacerbations 
in health 
3.2. Health advice seeking 
3.3. CF complications 
3.4. Physical development 
3.5. Diet, enzymes and digestion 
3.6. Speaking to health team 
3.7. Information about aspects of 
non-CF health e.g. migraines, 
dental, flu jab 
3.8. Home adjustments (e.g. 
showerheads, air purifier) 
 
4. Daily living issues and occupation 
4.1. Education inc. school and 
university attendance or 
exams 
4.2. Employment and interviews 
4.3. DLA, mobility and benefits 
4.4. Smokers 
4.5. Fitness and running 
4.6. Non-CF issues e.g. heating at 
home 
4.7. Past-times and hobbies 
4.8. Fundraising 
4.9. Travel insurance and 
healthcare abroad 
 
5. Psychosocial processes and issues 
5.1. Adjustment and transitions 
5.2. Friends not understanding 
5.3. Feeling different or “special” 
5.4. Hiding symptoms from others e.g. 
suppressing cough 
5.5. Emotions inc. low mood, anxiety, fear 
5.6. Anger at illness and other’s waste of 
health 
5.7. Coping 
5.8. Body image and weight 
5.9. “Invisible” illness 




6.1. Fear of what the future holds 
6.2. Hope 
6.3. Pregnancy, fertility and genetics 
6.4. Parenting 
6.5. Morality of having children 
6.6. Politics and changes in health service 
 
7. Nature of post 
7.1. Giving condolences after a death 
7.2. Well-wishing 
7.3. Use of humour 
7.4. Diffuse potential arguments 
 




7.8. Sharing experiences 
7.9. Giving information or advice 
7.10. Providing opinion or alternative 
viewpoint 
7.11. Seeking support 
7.12. Thanks 
7.13. Clarifying tone / intention 
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APPENDIX I: EXAMPLE OF A FRAMEWORK ANALYSIS DATA MATRIX 




antibiotics and dosage 
b) IV anitbiotics c) Blood Tests 
P1; Female, 25yo Providing info on Tobra and 
influential factors on dosage 
(weight, kidney function). 
Also giving info on nebs 
(order of meds, "prettied up") 
Coincides with periods, body 
has a sixth sense. Makes IVs 
more difficult to cope with.  
Feel the benefit after 7 days, 
next week clears up. 
Sometimes not as effective 
though 
Taking Tobi bloods from port 
instead of regular veins - 
same results. Empathising 
with frustration when bloods 
get lost etc. Painful re-
attempts, some staff better 
than others. Hypnotherapy 
helped when younger - 
needed restraining, now suck 
thumb for comfort when they 
jab me.  
P2; Female, 29yo       
P3; Female, 25yo   Seeking advice bronchoscopy 
- whether more IVs needed 
afterwards. Providing 
experience of feeling better 
after few days of Ivs, trusting 
instincts on need for 
treatment. 
  
P4; Female, 24yo       
P5; Male, 32yo   Frequency of IVs decreased 
since stopping work, cost less 
to society. Impact of IVs can 
vary, days or weeks to feel it. 
Sometimes feel rubbish doing 
Ivs. Wee smelling! 
  
P6; Male, 31yo Using salbutamol and oral abs 
to combat cold. Sharing to see 
if others have input on 
possible problems 
    
P7; Female, 28yo Seeking help with and 
discussing dosage of Tobra. 
Sharing experience of saline 
to hydrate lungs. Unable to 
share if funny taste due to 
cold! 
Port makes it easier to get 
access for IVs compared to 
Venflon, put it off for 10 
years. Veins burst = lumps, 
anesthetist better at putting in  
  
P8; Female, 26yo Explaining hypertonic saline, 
concentrations and 
mechanisms of action. Asking 
for different abs at clinic 
  Giving blood not a big deal, 
it's a pain especially when 
they miss, hit nerves, lose 
vials but it's necessary. Ports 
can be easier if hate needles. 
P9; Female, 27yo Requirement for blood tests 
when taking Tobra 
  Tobra dose check done via 
finger prick, few pricks 
needed to get enough blood. 
P10; Male, 38yo   Developed reactions to most 
IVs, cumulative effect over 
the years. 
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APPENDIX J: JOURNAL OF CYSTIC FIBROSIS AUTHOR GUIDELINES 
 
The Official Journal of the European Cystic Fibrosis Society  
 
Journal of Cystic Fibrosis publishes original scientific articles, editorials, case reports, short communications and other 
information relevant to cystic fibrosis and is published four times a year. Accepted papers become the copyright of the 
Journal and are accepted on the understanding that they have not been published, and are not being considered for 
publication elsewhere and are subject to editorial revision.  
 
Online Submission of Manuscripts to the Journal of Cystic Fibrosis:  
Submission and peer review of all papers is now conducted entirely online, increasing efficiency for editors, authors, 
and reviewers, and enhancing publication speed. Submit online at: http://ees.elsevier.com/jcf/  
Authors are guided stepwise through the entire process, and are kept abreast of the progress of their paper at each stage. 
The system creates PDF version of the submitted manuscript for peer review, revision and proofing. All correspondence, 
including the Editor's decision and request for revisions, is conducted by e-mail. 
Authors requesting further information on online submission are strongly encouraged to view the system, including a 
tutorial, at http://ees.elsevier.com/jcf. A comprehensive Author Support service is also available to answer additional 
enquiries at authorsupport@elsevier.com.  
 
Cover letter  
Corresponding authors must provide a cover letter which includes statements answering the following questions: 
• Has the work been seen and approved by all co-authors?  
• How is the work clinically relevant, and how does it add to existing research?  
• Have papers closely related to the submitted manuscript been published or submitted for publication 
elsewhere? If so please provide details.  
Failure to provide a cover letter addressing each of the questions above will result in the paper being returned to the 
author. The cover letter must be uploaded as a separate submission item. 
 
Title  
Your title page, numbered as 1, should give the title in capital letters (not exceeding 100 letters), a running title (not 
exceeding 50 letters) and the authors' names (as they are to appear), affiliations and complete addresses, including postal 
(zip) codes. The author and address to whom correspondence should be sent must be clearly indicated. Please supply 
telephone, fax and e-mail numbers for the corresponding author. Avoid use of extraneous words such as "study", 
"investigation", etc. If data from the manuscript have been presented at a meeting, list the full name, date and location of 
the meeting and reference any previously abstracts in the bibliography. 
 
Abstracts  
An abstract of your manuscript, summarizing the content, should be provided. A maximum of 150 words, should be 
written in a structured manner (for original articles only) since this will be the only part of the article studied by some 
readers. In original articles, the Abstract should consist of 4 paragraphs, labelled Background, Methods, Results, and 
Conclusions. They should briefly describe the problem being addressed in the study, how the study was performed and 
which measurements were carried out, the most relevant results, and what the authors conclude from the results.  
 
Reference Format  
Manuscripts should use the 'Vancouver' style for references, which should be numbered consecutively (in parentheses) 
in the order in which they are first cited in the text and listed at the end of the paper. For journal references, all authors 
should be included when there are six or less (first three only when seven or more), followed by the title of article, name 
of journal abbreviated according to British Standard 4148: 1975 (or left in full), year, volume, and first and last pages. 
For example:  
1. Tockman MS, Anthonisen MD, Wright EC et al. Airways obstruction and the risk of lung cancer. Ann Intern Med 
1987; 106:512-518.  
For book references, the author(s) should be followed by the chapter title (if appropriate), editor(s) (if applicable), book 
title, place of publication, publisher, year and page numbers.  
For example:  
2. Colby VT, Carrington CB. Infiltrative lung disease. In: Thurlbeck WM, ed. Pathology of the Lung. New York: 
Thieme Medical Publishers, 1988.  
 
Figures  
Figures of good quality should be submitted online as a separate file. For detailed instructions on the preparation of 
electronic artwork, consult: http://www.elsevier.com/authors. Permission to reproduce illustrations should always be 
obtained before submission and details included with the captions.  
 
Tables  
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Tables should be typed with double spacing each on a separate file, numbered consecutively with Arabic numerals, and 




A list of three to six keywords should be supplied: full instructions are provided when submitting the article online.  
 
Types of submission  
 
Short Communication  
1,200 words plus no more than 3 figures or tables in total 20 references 
Original articles  
Original research papers should contain no more than 3,000 words plus no more than 5 figures or tables in total and 30 
references. The abstract should consist of 4 paragraphs, labelled Background, Methods, Results, and Conclusions. 
Review articles  
Review papers should be authoritative, well referenced reviews of a relevant subject and should not contain more than 
5,000 words, and 30 references with no more than six figures or tables.  
 
Units & Abbreviations  
These should be given in SI units with the traditional equivalent in parentheses where appropriate. All other 
abbreviations or acronyms should be defined on first appearance in the text. Use a capital letter for proprietary names of 




All authors should have made substantial contributions to all the following: (1) the conception and design of the study, 
or acquisition of the data, or analysis and interpretation of data, (2) drafting or revising it critically for important 
intellectual content, (3) final approval of the version to be submitted. 
 
Acknowledgements  
All contributors who do not meet the criteria for authorship as defined above should be listed in an acknowledgements 
section. Examples of those who might be acknowledged include a person who provided purely technical help, writing 
assistance, or a department chair who provided only general support. Authors should disclose whether they had any 
writing assistance and identify the entity that paid for this assistance. 
 
Conflict of interest  
The potential for conflict of interest exists when an author (or the author's institution), reviewer or editor has financial or 
personal relationships that may inappropriately influence his or her actions. Editors and reviewers for the journal are 
responsible for disclosing to the Chief Editor any personal or financial relationship that may bias their work during the 
peer review process. 
Authors are specifically asked to reflect on financial conflicts of interest (such as employment, consultancy, stock 
ownership, honoraria and paid expert testimony) as well as other forms of conflict of interest, including personal, 
academic and intellectual issues. 
At the end of the text, under a subheading "Conflict of interest statement" all authors must disclose any financial and 
personal relationships with other people or organisations that could inappropriately influence (bias) their work. 
Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert 
testimony, patent applications/registrations, and grants or other funding.  
 
Role of the funding source  
All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role 
of study sponsors, if any, in the study design, in the collection, analysis and interpretation of data; in the writing of the 
manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, 
the authors should so state.  
 
Randomised controlled trials  
All randomised controlled trials submitted for publication in the Journal of Cystic Fibrosis should include a completed 
Consolidated Standards of Reporting Trials (CONSORT) flow chart. Please refer to the CONSORT statement website at 
http://www.consort-statement.org for more information. Journal of Cystic Fibrosis has adopted the proposal from the 
International Committee of Medical Journal Editors (ICMJE) which require, as a condition of consideration for 
publication of clinical trials, registration in a public trials registry. Trials must register at or before the onset of patient 
enrolment. The clinical trial registration number should be included at the end of the abstract of the article. For this 
purpose, a clinical trial is defined as any research study that prospectively assigns human participants or groups of 
humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related 
interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, 
surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care changes). Health 
outcomes include any biomedical or health-related measures obtained in patients or participants, including 
pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the 
medical intervention is not at the discretion of the investigator) will not require registration. Further information can be 
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found at http://www.icmje.org  
 
Disclosure of Clinical Trial Results  
In line with the position of the International Committee of Medical Journal Editors , the journal will not consider results 
posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted 
are presented in the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other 
circumstances (eg, investors' meetings) is discouraged and may jeopardise consideration of the manuscript. Authors 
should fully disclose all posting in registries of results of the same or closely related work. 
 
Ethics  
Work on human beings that is submitted to Respiratory Medicine should comply with the principles laid down in the 
Declaration of Helsinki; Recommendations guiding physicians in biomedical research involving human subjects. 
Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 29th World Medical 
Assembly, Tokyo, Japan, October 1975, the 35th World Medical Assembly, Venice, Italy, October 1983, and the 41st 
World Medical Assembly, Hong Kong, September 1989. The manuscript should contain a statement that the work has 
been approved by the appropriate ethical committees related to the institution(s) in which it was performed and that 
subjects gave informed consent to the work. Studies involving experiments with animals must state that their care was in 




Accepted papers become the copyright of the Journal and are accepted on the understanding that they have not been 
published, are not being considered for publication elsewhere and are subject to editorial revision. If papers closely 
related to the submitted manuscript have been published or submitted for publication elsewhere, the author must state 
this in their cover letter Upon acceptance of an article, authors will be asked to sign a "Journal Publishing Agreement" 
(for more information on this and copyright see http://www.elsevier.com/authors). Acceptance of the agreement will 
ensure the widest possible dissemination of information. An e-mail (or letter) will be sent to the corresponding author 
confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form. 
If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright 
owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases : contact e-
mail healthpermissions@elsevier.com. Requests may also be completed online via the Elsevier homepage (  
http://www.elsevier.com/locate/permissions). 
 
Permissions Information  
If illustrations are borrowed from published sources, written permission must be obtained from both publisher and 
author, and a credit line giving the source added to the legend. If text material totalling 250 to 300 words, or any tables, 
are borrowed verbatim from published sources, written permission is required from both publisher and author. With 
shorter quotations, it is sufficient to add a bibliographic credit. Permission letters for reproduced text or illustration must 
accompany the manuscript. If you have been unable to obtain permission, please point this out.  
 
Proofs  
Proofs will be sent to the authors to be carefully checked for printer's errors. Changes or additions to the edited 
manuscript cannot be allowed at this stage. Corrected proofs should be returned to the publisher within 2 days of receipt. 
 
Reprints/Author Benefits  
The Journal of Cystic Fibrosis has no page charges. Reprints. Twenty Five free reprints will be supplied per article. The 
publisher will send authors a form enabling further reprints to be ordered at prices listed on the form. 
 
Accepted Articles  
For the facility to track accepted articles and set email alerts to inform you of when an article's status has changed visit 
http://authors.elsevier.com/TrackPaper.html. There are also details on artwork guidelines, copyright information, 
frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those 
related to proofs, are provided after registration of an article for publication. 
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Elsevier has established agreements and developed policies to allow authors who publish in Elsevier journals to comply 
with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about 
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